1
|
Meldrum K, Evans SJ, Burgum MJ, Doak SH, Clift MJD. Determining the toxicological effects of indoor air pollution on both a healthy and an inflammatory-comprised model of the alveolar epithelial barrier in vitro. Part Fibre Toxicol 2024; 21:25. [PMID: 38760786 PMCID: PMC11100169 DOI: 10.1186/s12989-024-00584-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Accepted: 04/20/2024] [Indexed: 05/19/2024] Open
Abstract
Exposure to indoor air pollutants (IAP) has increased recently, with people spending more time indoors (i.e. homes, offices, schools and transportation). Increased exposures of IAP on a healthy population are poorly understood, and those with allergic respiratory conditions even less so. The objective of this study, therefore, was to implement a well-characterised in vitro model of the human alveolar epithelial barrier (A549 + PMA differentiated THP-1 incubated with and without IL-13, IL-5 and IL-4) to determine the effects of a standardised indoor particulate (NIST 2583) on both a healthy lung model and one modelling a type-II (stimulated with IL-13, IL-5 and IL-4) inflammatory response (such as asthma).Using concentrations from the literature, and an environmentally appropriate exposure we investigated 232, 464 and 608ng/cm2 of NIST 2583 respectively. Membrane integrity (blue dextran), viability (trypan blue), genotoxicity (micronucleus (Mn) assay) and (pro-)/(anti-)inflammatory effects (IL-6, IL-8, IL-33, IL-10) were then assessed 24 h post exposure to both models. Models were exposed using a physiologically relevant aerosolisation method (VitroCell Cloud 12 exposure system).No changes in Mn frequency or membrane integrity in either model were noted when exposed to any of the tested concentrations of NIST 2583. A significant decrease (p < 0.05) in cell viability at the highest concentration was observed in the healthy model. Whilst cell viability in the "inflamed" model was decreased at the lower concentrations (significantly (p < 0.05) after 464ng/cm2). A significant reduction (p < 0.05) in IL-10 and a significant increase in IL-33 was seen after 24 h exposure to NIST 2583 (464, 608ng/cm2) in the "inflamed" model.Collectively, the results indicate the potential for IAP to cause the onset of a type II response as well as exacerbating pre-existing allergic conditions. Furthermore, the data imposes the importance of considering unhealthy individuals when investigating the potential health effects of IAP. It also highlights that even in a healthy population these particles have the potential to induce this type II response and initiate an immune response following exposure to IAP.
Collapse
Affiliation(s)
- Kirsty Meldrum
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK.
| | - Stephen J Evans
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK
| | - Michael J Burgum
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK
| | - Martin J D Clift
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK.
| |
Collapse
|
2
|
Jeliazkova N, Longhin E, El Yamani N, Rundén-Pran E, Moschini E, Serchi T, Vrček IV, Burgum MJ, Doak SH, Cimpan MR, Rios-Mondragon I, Cimpan E, Battistelli CL, Bossa C, Tsekovska R, Drobne D, Novak S, Repar N, Ammar A, Nymark P, Di Battista V, Sosnowska A, Puzyn T, Kochev N, Iliev L, Jeliazkov V, Reilly K, Lynch I, Bakker M, Delpivo C, Sánchez Jiménez A, Fonseca AS, Manier N, Fernandez-Cruz ML, Rashid S, Willighagen E, D Apostolova M, Dusinska M. A template wizard for the cocreation of machine-readable data-reporting to harmonize the evaluation of (nano)materials. Nat Protoc 2024:10.1038/s41596-024-00993-1. [PMID: 38755447 DOI: 10.1038/s41596-024-00993-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 02/20/2024] [Indexed: 05/18/2024]
Abstract
Making research data findable, accessible, interoperable and reusable (FAIR) is typically hampered by a lack of skills in technical aspects of data management by data generators and a lack of resources. We developed a Template Wizard for researchers to easily create templates suitable for consistently capturing data and metadata from their experiments. The templates are easy to use and enable the compilation of machine-readable metadata to accompany data generation and align them to existing community standards and databases, such as eNanoMapper, streamlining the adoption of the FAIR principles. These templates are citable objects and are available as online tools. The Template Wizard is designed to be user friendly and facilitates using and reusing existing templates for new projects or project extensions. The wizard is accompanied by an online template validator, which allows self-evaluation of the template (to ensure mapping to the data schema and machine readability of the captured data) and transformation by an open-source parser into machine-readable formats, compliant with the FAIR principles. The templates are based on extensive collective experience in nanosafety data collection and include over 60 harmonized data entry templates for physicochemical characterization and hazard assessment (cell viability, genotoxicity, environmental organism dose-response tests, omics), as well as exposure and release studies. The templates are generalizable across fields and have already been extended and adapted for microplastics and advanced materials research. The harmonized templates improve the reliability of interlaboratory comparisons, data reuse and meta-analyses and can facilitate the safety evaluation and regulation process for (nano) materials.
Collapse
Affiliation(s)
| | - Eleonora Longhin
- Health Effects Laboratory, Department of Environmental Chemistry & Health Effects, The Climate and Environmental Research Institute NILU, Kjeller, Norway
| | - Naouale El Yamani
- Health Effects Laboratory, Department of Environmental Chemistry & Health Effects, The Climate and Environmental Research Institute NILU, Kjeller, Norway
| | - Elise Rundén-Pran
- Health Effects Laboratory, Department of Environmental Chemistry & Health Effects, The Climate and Environmental Research Institute NILU, Kjeller, Norway
| | - Elisa Moschini
- Environmental Health group, Department of Environmental Research and Innovation, Luxembourg Institute of Science and Technology, Belvaux, Luxembourg
| | - Tommaso Serchi
- Environmental Health group, Department of Environmental Research and Innovation, Luxembourg Institute of Science and Technology, Belvaux, Luxembourg
| | | | - Michael J Burgum
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, Wales, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, Wales, UK
| | | | | | - Emil Cimpan
- Department of Computer Science, Electrical Engineering and Mathematical Sciences, Western Norway University of Applied Sciences, Bergen, Norway
| | | | - Cecilia Bossa
- Environment and Health Department, Istituto Superiore di Sanità, Rome, Italy
| | - Rositsa Tsekovska
- Medical and Biological Research Laboratory, Roumen Tsanev Institute of Molecular Biology-Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Damjana Drobne
- Department of Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia
| | - Sara Novak
- Department of Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia
| | - Neža Repar
- Department of Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia
| | - Ammar Ammar
- Department of Bioinformatics-BiGCaT, NUTRIM, Maastricht University, Maastricht, the Netherlands
| | - Penny Nymark
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Veronica Di Battista
- BASF SE, Material Physics, Carl Bosch straße, Ludwigshafen, Germany
- Department of Environmental and Resource Engineering, DTU, Kgs. Lyngby, Denmark
| | - Anita Sosnowska
- QSAR Lab Ltd., Gdańsk, Poland
- University of Gdańsk, Faculty of Chemistry, Gdansk, Poland
| | - Tomasz Puzyn
- QSAR Lab Ltd., Gdańsk, Poland
- University of Gdańsk, Faculty of Chemistry, Gdansk, Poland
| | - Nikolay Kochev
- Ideaconsult Ltd., Sofia, Bulgaria
- Department of Analytical Chemistry and Computer Chemistry, Faculty of Chemistry, University of Plovdiv, Plovdiv, Bulgaria
| | | | | | - Katie Reilly
- School of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Iseult Lynch
- School of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Martine Bakker
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | | | - Araceli Sánchez Jiménez
- Spanish National Institute of Health and Safety, Centro Nacional de Verificación de Maquinaria, Barakaldo, Spain
| | - Ana Sofia Fonseca
- National Research Centre for the Working Environment, Copenhagen, Denmark
| | - Nicolas Manier
- Ecotoxicology of Substances and Environmental Matrices Unit, French National Institute for Industrial Environment and Risks, Verneuil-en-Halatte, France
| | - María Luisa Fernandez-Cruz
- Department of Environment and Agronomy, National Institute for Agriculture and Food Research and Technology, Spanish National Research Council, Madrid, Spain
| | - Shahzad Rashid
- Institute of Occupational Medicine, Research Avenue North, Edinburgh, UK
| | - Egon Willighagen
- Department of Bioinformatics-BiGCaT, NUTRIM, Maastricht University, Maastricht, the Netherlands
| | - Margarita D Apostolova
- Medical and Biological Research Laboratory, Roumen Tsanev Institute of Molecular Biology-Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Maria Dusinska
- Health Effects Laboratory, Department of Environmental Chemistry & Health Effects, The Climate and Environmental Research Institute NILU, Kjeller, Norway.
| |
Collapse
|
3
|
Burgum MJ, Ulrich C, Partosa N, Evans SJ, Gomes C, Seiffert SB, Landsiedel R, Honarvar N, Doak SH. Adapting the in vitro micronucleus assay (OECD Test Guideline No. 487) for testing of manufactured nanomaterials: recommendations for best practices. Mutagenesis 2024; 39:205-217. [PMID: 38502821 DOI: 10.1093/mutage/geae010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Accepted: 03/18/2024] [Indexed: 03/21/2024] Open
Abstract
The current Organisation for Economic Co-Operation and Development test guideline number 487 (OECD TG No. 487) provides instruction on how to conduct the in vitro micronucleus assay. This assay is one of the gold standard approaches for measuring the mutagenicity of test items; however, it is directed at testing low molecular weight molecules and may not be appropriate for particulate materials (e.g. engineered nanoparticles [ENPs]). This study aimed to adapt the in vitro micronucleus assay for ENP testing and underpins the development of an OECD guidance document. A harmonized, nano-specific protocol was generated and evaluated by two independent laboratories. Cell lines utilized were human lymphoblastoid (TK6) cells, human liver hepatocytes (HepG2) cells, Chinese hamster lung fibroblast (V79) cells, whole blood, and buffy coat cells from healthy human volunteers. These cells were exposed to reference ENPs from the Joint Research Council (JRC): SiO2 (RLS-0102), Au5nm and Au30nm (RLS-03, RLS-010), CeO2 (NM212), and BaSO4 (NM220). Tungsten carbide-cobalt (WC/Co) was used as a trial particulate positive control. The chemical controls were positive in all cell cultures, but WC/Co was only positive in TK6 and buffy coat cells. In TK6 cells, mutagenicity was observed for SiO2- and both Au types. In HepG2 cells, Au5nm and SiO2 showed sub-two-fold increases in micronuclei. In V79 cells, whole blood, and buffy coat cells, no genotoxicity was detected with the test materials. The data confirmed that ENPs could be tested with the harmonized protocol, additionally, concordant data were observed across the two laboratories with V79 cells. WC/Co may be a suitable particulate positive control in the in vitro micronucleus assay when using TK6 and buffy coat cells. Detailed recommendations are therefore provided to adapt OECD TG No. 487 for testing ENP.
Collapse
Affiliation(s)
- Michael J Burgum
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, United Kingdom
| | - Clarissa Ulrich
- BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany
| | - Natascha Partosa
- BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany
| | - Stephen J Evans
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, United Kingdom
| | - Caroline Gomes
- BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany
| | | | - Robert Landsiedel
- BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany
- Free University of Berlin, Pharmacy - Pharmacology and Toxicology, 14195 Berlin, Germany
| | - Naveed Honarvar
- BASF SE, Experimental Toxicology and Ecology, 67056, Ludwigshafen, Germany
| | - Shareen H Doak
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, United Kingdom
| |
Collapse
|
4
|
Chapman KE, Shah UK, Fletcher JF, Johnson GE, Doak SH, Jenkins GJS. An integrated in vitro carcinogenicity test that distinguishes between genotoxic carcinogens, non-genotoxic carcinogens, and non-carcinogens. Mutagenesis 2024; 39:69-77. [PMID: 38301659 DOI: 10.1093/mutage/geae004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Accepted: 01/29/2024] [Indexed: 02/03/2024] Open
Abstract
Chemical safety testing plays a crucial role in product and pharmacological development, as well as chemoprevention; however, in vitro genotoxicity safety tests do not always accurately predict the chemicals that will be in vivo carcinogens. If chemicals test positive in vitro for genotoxicity but negative in vivo, this can contribute to unnecessary testing in animals used to confirm erroneous in vitro positive results. Current in vitro tests typically evaluate only genotoxicity endpoints, which limits their potential to detect non-genotoxic carcinogens. The frequency of misleading in vitro positive results can be high, leading to a requirement for more informative in vitro tests. It is now recognized that multiple-endpoint genotoxicity testing may aid more accurate detection of carcinogens and non-carcinogens. The objective of this review was to evaluate the utility of our novel, multiple-endpoint in vitro test, which uses multiple cancer-relevant endpoints to predict carcinogenic potential. The tool assessed micronucleus frequency, p53 expression, p21 expression, mitochondrial respiration, cell cycle abnormalities and, uniquely, cell morphology changes in human lymphoblastoid cell lines, TK6 and MCL-5. The endpoints were used to observe cellular responses to 18 chemicals within the following categories: genotoxic carcinogens, non-genotoxic carcinogens, toxic non-carcinogens, and misleading in vitro positive and negative agents. The number of endpoints significantly altered for each chemical was considered, alongside the holistic Integrated Signature of Carcinogenicity score, derived from the sum of fold changes for all endpoints. Following the calculation of an overall score from these measures, carcinogens exhibited greater potency than non-carcinogens. Genotoxic carcinogens were generally more potent than non-genotoxic carcinogens. This novel approach therefore demonstrated potential for correctly predicting whether chemicals with unknown mechanism may be considered carcinogens. Overall, while further validation is recommended, the test demonstrates potential for the identification of carcinogenic compounds. Adoption of the approach could enable reduced animal use in carcinogenicity testing.
Collapse
Affiliation(s)
- Katherine E Chapman
- Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United Kingdom
| | - Ume-Kulsoom Shah
- Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United Kingdom
| | - Jessica F Fletcher
- Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United Kingdom
| | - George E Johnson
- Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United Kingdom
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United Kingdom
| | - Gareth J S Jenkins
- Institute of Life Science, Swansea University Medical School, Swansea, SA2 8PP, United Kingdom
| |
Collapse
|
5
|
Stannard LM, Doherty A, Chapman KE, Doak SH, Jenkins GJ. Multi-endpoint analysis of cadmium chloride-induced genotoxicity shows role for reactive oxygen species and p53 activation in DNA damage induction, cell cycle irregularities, and cell size aberrations. Mutagenesis 2024; 39:13-23. [PMID: 37555614 PMCID: PMC10851103 DOI: 10.1093/mutage/gead025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Accepted: 12/12/2023] [Indexed: 08/10/2023] Open
Abstract
Cadmium chloride (CdCl2) is a known genotoxic carcinogen, with a mechanism of action thought to partly involve the generation of reactive oxygen species (ROS). We applied here a multi-endpoint approach in vitro to explore the impact of CdCl2 on both the genome and on wider cell biology pathways relevant to cancer. Multi-endpoint approaches are believed to offer greater promise in terms of understanding the holistic effects of carcinogens in vitro. This richer understanding may help better classification of carcinogens as well as allowing detailed mechanisms of action to be identified. We found that CdCl2 caused DNA damage [micronuclei (MN)] in both TK6 and NH32 cells in a dose-dependent manner after 4 h exposure (plus 23 h recovery), with lowest observable effect levels (LOELs) for MN induction of 1 μM (TK6) and 1.6 μM (NH32). This DNA damage induction in TK6 cells was ROS dependent as pretreatment with the antioxidant N-Acetyl Cysteine (1 mM), abrogated this effect. However, 2',7'-dichlorofluorescin diacetate was not capable of detecting the ROS induced by CdCl2. The use of NH32 cells allowed an investigation of the role of p53 as they are a p53 null cell line derived from TK6. NH32 showed a 10-fold increase in MN in untreated cells and a similar dose-dependent effect after CdCl2 treatment. In TK6 cells, CdCl2 also caused activation of p53 (accumulation of total and phosphorylated p53), imposition of cell cycle checkpoints (G2/M) and intriguingly the production of smaller and more eccentric (elongated) cells. Overall, this multi-endpoint study suggests a carcinogenic mechanism of CdCl2 involving ROS generation, oxidative DNA damage and p53 activation, leading to cell cycle abnormalities and impacts of cell size and shape. This study shows how the integration of multiple cell biology endpoints studied in parallel in vitro can help mechanistic understanding of how carcinogens disrupt normal cell biology.
Collapse
Affiliation(s)
- Leanne M Stannard
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea SA28PP, United Kingdom
| | - Ann Doherty
- Safety Innovation, Astra Zeneca, Cambridge, United Kingdom
| | - Katherine E Chapman
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea SA28PP, United Kingdom
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea SA28PP, United Kingdom
| | - Gareth J Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea SA28PP, United Kingdom
| |
Collapse
|
6
|
Brown S, Evans SJ, Burgum MJ, Meldrum K, Herridge J, Akinbola B, Harris LG, Jenkins R, Doak SH, Clift MJD, Wilkinson TS. An In Vitro Model to Assess Early Immune Markers Following Co-Exposure of Epithelial Cells to Carbon Black (Nano)Particles in the Presence of S. aureus: A Role for Stressed Cells in Toxicological Testing. Biomedicines 2024; 12:128. [PMID: 38255233 PMCID: PMC10813740 DOI: 10.3390/biomedicines12010128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 12/21/2023] [Accepted: 12/25/2023] [Indexed: 01/24/2024] Open
Abstract
The exposure of human lung and skin to carbon black (CB) is continuous due to its widespread applications. Current toxicological testing uses 'healthy' cellular systems; however, questions remain whether this mimics the everyday stresses that human cells are exposed to, including infection. Staphylococcus aureus lung and skin infections remain prevalent in society, and include pneumonia and atopic dermatitis, respectively, but current in vitro toxicological testing does not consider infection stress. Therefore, investigating the effects of CB co-exposure in 'stressed' infected epithelial cells in vitro may better approximate true toxicity. This work aims to study the impact of CB exposure during Staphylococcus aureus infection stress in A549 (lung) and HaCaT (skin) epithelial cells. Physicochemical characterisation of CB confirmed its dramatic polydispersity and potential to aggregate. CB significantly inhibited S. aureus growth in cell culture media. CB did not induce cytokines or antimicrobial peptides from lung and skin epithelial cells, when given alone, but did reduce HaCaT and A549 cell viability to 55% and 77%, respectively. In contrast, S. aureus induced a robust interleukin (IL)-8 response in both lung and skin epithelial cells. IL-6 and human beta defensin (hβD)-2 could only be detected when cells were stimulated with S. aureus with no decreases in cell viability. However, co-exposure to CB (100 µg/mL) and S. aureus resulted in significant inhibition of IL-8 (compared to S. aureus alone) without further reduction in cell viability. Furthermore, the same co-exposure induced significantly more hβD-2 (compared to S. aureus alone). This work confirms that toxicological testing in healthy versus stressed cells gives significantly different responses. This has significant implications for toxicological testing and suggests that cell stresses (including infection) should be included in current models to better represent the diversity of cell viabilities found in lung and skin within a general population. This model will have significant application when estimating CB exposure in at-risk groups, such as factory workers, the elderly, and the immunocompromised.
Collapse
Affiliation(s)
- Scott Brown
- Microbiology and Infectious Disease, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK
| | - Stephen J. Evans
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK (M.J.D.C.)
| | - Michael J. Burgum
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK (M.J.D.C.)
| | - Kirsty Meldrum
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK (M.J.D.C.)
| | - Jack Herridge
- Microbiology and Infectious Disease, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK
| | - Blessing Akinbola
- Microbiology and Infectious Disease, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK
| | - Llinos G. Harris
- Microbiology and Infectious Disease, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK
| | - Rowena Jenkins
- Microbiology and Infectious Disease, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK
| | - Shareen H. Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK (M.J.D.C.)
| | - Martin J. D. Clift
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK (M.J.D.C.)
| | - Thomas S. Wilkinson
- Microbiology and Infectious Disease, Institute of Life Science, Swansea University Medical School (SUMS), Swansea SA2 8PP, UK
| |
Collapse
|
7
|
Jovic TH, Nicholson T, Arora H, Nelson K, Doak SH, Whitaker IS. A comparative analysis of pulp-derived nanocelluloses for 3D bioprinting facial cartilages. Carbohydr Polym 2023; 321:121261. [PMID: 37739492 DOI: 10.1016/j.carbpol.2023.121261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 07/28/2023] [Accepted: 08/03/2023] [Indexed: 09/24/2023]
Abstract
Nanocelluloses have attracted significant interest in the field of bioprinting, with previous research outlining the value of nanocellulose fibrils and bacterial nanocelluloses for 3D bioprinting tissues such as cartilage. We have recently characterised three distinct structural formulations of pulp-derived nanocelluloses: fibrillar (NFC), crystalline (NCC) and blend (NCB), exhibiting variation in pore geometry and mechanical properties. In light of the characterisation of these three distinct entities, this study investigated whether these structural differences translated to differences in printability, chondrogenicity or biocompatibility for 3D bioprinting anatomical structures with human nasoseptal chondrocytes. Composite nanocellulose-alginate bioinks (75:25 v/v) of NFC, NCC and NCB were produced and tested for print resolution and fidelity. NFC offered superior print resolution whereas NCB demonstrated the best post-printing shape fidelity. Biologically, chondrogenicity was assessed using real time quantitative PCR, dimethylmethylene blue assays and histology. All biomaterials showed an increase in chondrogenic gene expression and extracellular matrix production over 21 days, but this was superior in the NCC bioink. Biocompatibility assessments revealed an increase in cell number and metabolism over 21 days in the NCC and NCB formulations. Nanocellulose augments printability and chondrogenicity of bioinks, of which the NCC and NCB formulations offer the best biological promise for bioprinting cartilage.
Collapse
Affiliation(s)
- Thomas H Jovic
- Reconstructive Surgery and Regenerative Medicine Research Centre, Institute of Life Sciences 1, Swansea University, SA2 8PP, UK; Welsh Centre for Burns & Plastic Surgery, Morriston Hospital, Swansea SA6 6NL, UK.
| | | | | | | | | | - Iain S Whitaker
- Reconstructive Surgery and Regenerative Medicine Research Centre, Institute of Life Sciences 1, Swansea University, SA2 8PP, UK; Welsh Centre for Burns & Plastic Surgery, Morriston Hospital, Swansea SA6 6NL, UK
| |
Collapse
|
8
|
Doak SH, Andreoli C, Burgum MJ, Chaudhry Q, Bleeker EAJ, Bossa C, Domenech J, Drobne D, Fessard V, Jeliazkova N, Longhin E, Rundén-Pran E, Stępnik M, El Yamani N, Catalán J, Dusinska M. Current status and future challenges of genotoxicity OECD Test Guidelines for nanomaterials: a workshop report. Mutagenesis 2023; 38:183-191. [PMID: 37234002 PMCID: PMC10448853 DOI: 10.1093/mutage/gead017] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Indexed: 05/27/2023] Open
Abstract
Genotoxicity testing for nanomaterials remains challenging as standard testing approaches require some adaptation, and further development of nano-specific OECD Test Guidelines (TGs) and Guidance Documents (GDs) are needed. However, the field of genotoxicology continues to progress and new approach methodologies (NAMs) are being developed that could provide relevant information on the range of mechanisms of genotoxic action that may be imparted by nanomaterials. There is a recognition of the need for implementation of new and/or adapted OECD TGs, new OECD GDs, and utilization of NAMs within a genotoxicity testing framework for nanomaterials. As such, the requirements to apply new experimental approaches and data for genotoxicity assessment of nanomaterials in a regulatory context is neither clear, nor used in practice. Thus, an international workshop with representatives from regulatory agencies, industry, government, and academic scientists was convened to discuss these issues. The expert discussion highlighted the current deficiencies that exist in standard testing approaches within exposure regimes, insufficient physicochemical characterization, lack of demonstration of cell or tissue uptake and internalization, and limitations in the coverage of genotoxic modes of action. Regarding the latter aspect, a consensus was reached on the importance of using NAMs to support the genotoxicity assessment of nanomaterials. Also highlighted was the need for close engagement between scientists and regulators to (i) provide clarity on the regulatory needs, (ii) improve the acceptance and use of NAM-generated data, and (iii) define how NAMs may be used as part of weight of evidence approaches for use in regulatory risk assessments.
Collapse
Affiliation(s)
- Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Singelton Park, Swansea, SA2 8PP Wales, United Kingdom
| | - Cristina Andreoli
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - Michael J Burgum
- Institute of Life Science, Swansea University Medical School, Singelton Park, Swansea, SA2 8PP Wales, United Kingdom
| | - Qasim Chaudhry
- University of Chester, Parkgate Road, Chester, United Kingdom
| | - Eric A J Bleeker
- National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands
| | - Cecilia Bossa
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - Josefa Domenech
- Finnish Institute of Occupational Health, Box 40, Työterveyslaitos, 00032 Helsinki, Finland
| | - Damjana Drobne
- University of Ljubljana, Biotechnical Faculty, Department of Biology, Vecan pot 111, 1000 Ljubljana, Slovenia
| | - Valérie Fessard
- ANSES French Agency for Food, Environmental and Occupational Health and Safety, Fougères Laboratory, Toxicology of Contaminants Unit, 10b rue Claude Bourgelat, Fougères 35306, France
| | | | - Eleonora Longhin
- NILU-Norwegian Institute for Air Research, Instituttveien 18, Kjeller 2002, Norway
| | - Elise Rundén-Pran
- NILU-Norwegian Institute for Air Research, Instituttveien 18, Kjeller 2002, Norway
| | | | - Naouale El Yamani
- NILU-Norwegian Institute for Air Research, Instituttveien 18, Kjeller 2002, Norway
| | - Julia Catalán
- Finnish Institute of Occupational Health, Box 40, Työterveyslaitos, 00032 Helsinki, Finland
- Department of Anatomy, Embryology, and Genetics, University of Zaragoza, 50013 Zaragoza, Spain
| | - Maria Dusinska
- NILU-Norwegian Institute for Air Research, Instituttveien 18, Kjeller 2002, Norway
| |
Collapse
|
9
|
Braakhuis HM, Gremmer ER, Bannuscher A, Drasler B, Keshavan S, Rothen-Rutishauser B, Birk B, Verlohner A, Landsiedel R, Meldrum K, Doak SH, Clift MJD, Erdem JS, Foss OAH, Zienolddiny-Narui S, Serchi T, Moschini E, Weber P, Burla S, Kumar P, Schmid O, Zwart E, Vermeulen JP, Vandebriel RJ. Transferability and reproducibility of exposed air-liquid interface co-culture lung models. NanoImpact 2023; 31:100466. [PMID: 37209722 DOI: 10.1016/j.impact.2023.100466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 04/03/2023] [Accepted: 05/03/2023] [Indexed: 05/22/2023]
Abstract
BACKGROUND The establishment of reliable and robust in vitro models for hazard assessment, a prerequisite for moving away from animal testing, requires the evaluation of model transferability and reproducibility. Lung models that can be exposed via the air, by means of an air-liquid interface (ALI) are promising in vitro models for evaluating the safety of nanomaterials (NMs) after inhalation exposure. We performed an inter-laboratory comparison study to evaluate the transferability and reproducibility of a lung model consisting of the human bronchial cell line Calu-3 as a monoculture and, to increase the physiologic relevance of the model, also as a co-culture with macrophages (either derived from the THP-1 monocyte cell line or from human blood monocytes). The lung model was exposed to NMs using the VITROCELL® Cloud12 system at physiologically relevant dose levels. RESULTS Overall, the results of the 7 participating laboratories are quite similar. After exposing Calu-3 alone and Calu-3 co-cultures with macrophages, no effects of lipopolysaccharide (LPS), quartz (DQ12) or titanium dioxide (TiO2) NM-105 particles on the cell viability and barrier integrity were detected. LPS exposure induced moderate cytokine release in the Calu-3 monoculture, albeit not statistically significant in most labs. In the co-culture models, most laboratories showed that LPS can significantly induce cytokine release (IL-6, IL-8 and TNF-α). The exposure to quartz and TiO2 particles did not induce a statistically significant increase in cytokine release in both cell models probably due to our relatively low deposited doses, which were inspired by in vivo dose levels. The intra- and inter-laboratory comparison study indicated acceptable interlaboratory variation for cell viability/toxicity (WST-1, LDH) and transepithelial electrical resistance, and relatively high inter-laboratory variation for cytokine production. CONCLUSION The transferability and reproducibility of a lung co-culture model and its exposure to aerosolized particles at the ALI were evaluated and recommendations were provided for performing inter-laboratory comparison studies. Although the results are promising, optimizations of the lung model (including more sensitive read-outs) and/or selection of higher deposited doses are needed to enhance its predictive value before it may be taken further towards a possible OECD guideline.
Collapse
Affiliation(s)
- Hedwig M Braakhuis
- National Institute for Public Health & the Environment (RIVM), the Netherlands
| | - Eric R Gremmer
- National Institute for Public Health & the Environment (RIVM), the Netherlands
| | - Anne Bannuscher
- Adolphe Merkle Institute (AMI), University of Fribourg, Switzerland
| | - Barbara Drasler
- Adolphe Merkle Institute (AMI), University of Fribourg, Switzerland
| | - Sandeep Keshavan
- Adolphe Merkle Institute (AMI), University of Fribourg, Switzerland
| | | | | | | | - Robert Landsiedel
- BASF SE, Ludwigshafen, Germany; Free University of Berlin, Pharmacy - Pharmacology and Toxicology, Berlin, Germany
| | | | | | | | | | - Oda A H Foss
- National Institute of Occupational Health (STAMI), Norway
| | | | - Tommaso Serchi
- Luxembourg Institute of Science and Technology (LIST), Grand Duchy of Luxembourg, Luxembourg
| | - Elisa Moschini
- Luxembourg Institute of Science and Technology (LIST), Grand Duchy of Luxembourg, Luxembourg
| | - Pamina Weber
- Luxembourg Institute of Science and Technology (LIST), Grand Duchy of Luxembourg, Luxembourg
| | - Sabina Burla
- Luxembourg Institute of Science and Technology (LIST), Grand Duchy of Luxembourg, Luxembourg
| | - Pramod Kumar
- Comprehensive Pneumology Center (CPC-M) with the CPC-M bioArchive, Helmholtz Center Munich - Member of the German Center for Lung Research (DZL), Munich, Germany; Institute of Lung Health and Immunity, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany
| | - Otmar Schmid
- Comprehensive Pneumology Center (CPC-M) with the CPC-M bioArchive, Helmholtz Center Munich - Member of the German Center for Lung Research (DZL), Munich, Germany; Institute of Lung Health and Immunity, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany
| | - Edwin Zwart
- National Institute for Public Health & the Environment (RIVM), the Netherlands
| | - Jolanda P Vermeulen
- National Institute for Public Health & the Environment (RIVM), the Netherlands
| | - Rob J Vandebriel
- National Institute for Public Health & the Environment (RIVM), the Netherlands.
| |
Collapse
|
10
|
Jones LA, Conway GE, Nguyen-Chi A, Burnell S, Jenkins GJ, Conlan RS, Doak SH. Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer. Cell Mol Biol (Noisy-le-grand) 2023; 69:179-187. [PMID: 37329528 DOI: 10.14715/cmb/2023.69.4.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Indexed: 06/19/2023]
Abstract
The expression of six transmembrane epithelial antigen of the prostate (STEAP2) is increased in prostate cancer when compared to normal tissue, suggesting a role for STEAP2 in disease progression. This study aimed to determine whether targeting STEAP2 with an anti-STEAP2 polyclonal antibody (pAb) or CRISPR/Cas9 knockout influenced aggressive prostate cancer traits. Gene expression analysis of the STEAP gene family was performed in a panel of prostate cancer cell lines; C4-2B, DU145, LNCaP and PC3. The highest increases in STEAP2 gene expression were observed in C4-2B and LNCaP cells (p<0.001 and p<0.0001 respectively) when compared to normal prostate epithelial PNT2 cells. These cell lines were treated with an anti-STEAP2 pAb and their viability assessed. CRISPR/Cas9 technology was used to knockout STEAP2 from C4-2B and LNCaP cells and viability, proliferation, migration and invasion assessed. When exposed to an anti-STEAP2 pAb, cell viability significantly decreased (p<0.05). When STEAP2 was knocked out, cell viability and proliferation was significantly decreased when compared to wild-type cells (p<0.001). The migratory and invasive potential of knockout cells were also decreased. These data suggest that STEAP2 has a functional role in driving aggressive prostate cancer traits and could provide a novel therapeutic target for the treatment of prostate cancer.
Collapse
Affiliation(s)
- Leia A Jones
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| | - Gillian E Conway
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| | - Aimy Nguyen-Chi
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| | - Stephanie Burnell
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| | - Gareth J Jenkins
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| | - R Steven Conlan
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Faculty of Medicine, Health and Life Sciences, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| |
Collapse
|
11
|
Siivola KM, Burgum MJ, Suárez-Merino B, Clift MJD, Doak SH, Catalán J. Correction: a systematic quality evaluation and review of nanomaterial genotoxicity studies: a regulatory perspective. Part Fibre Toxicol 2022; 19:70. [PMID: 36575483 PMCID: PMC9795579 DOI: 10.1186/s12989-022-00509-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Affiliation(s)
- Kirsi M. Siivola
- grid.6975.d0000 0004 0410 5926Finnish Institute of Occupational Health, Box 40, 00032 Työterveyslaitos, Helsinki, Finland
| | - Michael J. Burgum
- grid.4827.90000 0001 0658 8800In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, SA2 8PP Singleton Park, Swansea, Wales, UK
| | | | - Martin J. D. Clift
- grid.4827.90000 0001 0658 8800In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, SA2 8PP Singleton Park, Swansea, Wales, UK
| | - Shareen H. Doak
- grid.4827.90000 0001 0658 8800In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, SA2 8PP Singleton Park, Swansea, Wales, UK
| | - Julia Catalán
- grid.6975.d0000 0004 0410 5926Finnish Institute of Occupational Health, Box 40, 00032 Työterveyslaitos, Helsinki, Finland ,grid.11205.370000 0001 2152 8769Department of Anatomy Embryology and Genetics, University of Zaragoza, 50013 Zaragoza, Spain
| |
Collapse
|
12
|
Llewellyn SV, Kermanizadeh A, Ude V, Jacobsen NR, Conway GE, Shah UK, Niemeijer M, Moné MJ, van de Water B, Roy S, Moritz W, Stone V, Jenkins GJS, Doak SH. Assessing the transferability and reproducibility of 3D in vitro liver models from primary human multi-cellular microtissues to cell-line based HepG2 spheroids. Toxicol In Vitro 2022; 85:105473. [PMID: 36108805 DOI: 10.1016/j.tiv.2022.105473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Revised: 09/02/2022] [Accepted: 09/08/2022] [Indexed: 11/16/2022]
Abstract
To reduce, replace, and refine in vivo testing, there is increasing emphasis on the development of more physiologically relevant in vitro test systems to improve the reliability of non-animal-based methods for hazard assessment. When developing new approach methodologies, it is important to standardize the protocols and demonstrate the methods can be reproduced by multiple laboratories. The aim of this study was to assess the transferability and reproducibility of two advanced in vitro liver models, the Primary Human multicellular microtissue liver model (PHH) and the 3D HepG2 Spheroid Model, for nanomaterial (NM) and chemical hazard assessment purposes. The PHH model inter-laboratory trial showed strong consistency across the testing sites. All laboratories evaluated cytokine release and cytotoxicity following exposure to titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles. No significant difference was observed in cytotoxicity or IL-8 release for the test materials. The data were reproducible with all three laboratories with control readouts within a similar range. The PHH model ZnO induced the greatest cytotoxicity response at 50.0 μg/mL and a dose-dependent increase in IL-8 release. For the 3D HepG2 spheroid model, all test sites were able to construct the model and demonstrated good concordance in IL-8 cytokine release and genotoxicity data. This trial demonstrates the successful transfer of new approach methodologies across multiple laboratories, with good reproducibility for several hazard endpoints.
Collapse
Affiliation(s)
- Samantha V Llewellyn
- In vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Ali Kermanizadeh
- University of Derby, School of Human Sciences, Derby DE22 1GB, UK
| | - Victor Ude
- Heriot Watt University, School of Engineering and Physical Sciences, Nano Safety Research Group, Edinburgh, UK
| | - Nicklas Raun Jacobsen
- National Research Centre for the Working Environment (NRCWE), Lersø Parkallé 105, DK-2100 Copenhagen, Denmark
| | - Gillian E Conway
- In vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Ume-Kulsoom Shah
- In vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Marije Niemeijer
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden 2333 CC, the Netherlands
| | - Martijn J Moné
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden 2333 CC, the Netherlands
| | - Bob van de Water
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden 2333 CC, the Netherlands
| | - Shambhu Roy
- MilliporeSigma, 14920 Broschart Road, Rockville, MD 20850, USA
| | | | - Vicki Stone
- Heriot Watt University, School of Engineering and Physical Sciences, Nano Safety Research Group, Edinburgh, UK
| | - Gareth J S Jenkins
- In vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Shareen H Doak
- In vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| |
Collapse
|
13
|
Coskun E, Singh N, Scanlan LD, Jaruga P, Doak SH, Dizdaroglu M, Nelson BC. Inhibition of human APE1 and MTH1 DNA repair proteins by dextran-coated γ-Fe 2O 3 ultrasmall superparamagnetic iron oxide nanoparticles. Nanomedicine (Lond) 2022; 17:2011-2021. [PMID: 36853189 PMCID: PMC10031551 DOI: 10.2217/nnm-2022-0204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023] Open
Abstract
Aim: To quantitatively evaluate the inhibition of human DNA repair proteins APE1 and MTH1 by dextran-coated γ-Fe2O3 ultrasmall superparamagnetic iron oxide nanoparticles (dUSPIONs). Materials & methods: Liquid chromatography-tandem mass spectrometry with isotope-dilution was used to measure the expression levels of APE1 and MTH1 in MCL-5 cells exposed to increasing doses of dUSPIONs. The expression levels of APE1 and MTH1 were measured in cytoplasmic and nuclear fractions of cell extracts. Results: APE1 and MTH1 expression was significantly inhibited in both cell fractions at the highest dUSPION dose. The expression of MTH1 was linearly inhibited across the full dUSPION dose range in both fractions. Conclusion: These findings warrant further studies to characterize the capacity of dUSPIONs to inhibit other DNA repair proteins in vitro and in vivo.
Collapse
Affiliation(s)
- Erdem Coskun
- Institute for Bioscience & Biotechnology Research, University of Maryland, Rockville, MD 20850, USA
| | - Neenu Singh
- Leicester School of Allied Health Sciences, Faculty of Health & Life Sciences, De Montfort University, The Gateway, Leicester, LE1 9BH, UK
| | - Leona D Scanlan
- California Environmental Protection Agency, Office of Environmental Health Hazard Assessment, 1001 I Street, Sacramento, CA 95814, USA
| | - Pawel Jaruga
- Biomolecular Measurement Division, National Institute of Standards & Technology, Gaithersburg, MD 20899, USA
| | - Shareen H Doak
- Institute of Life Science, Center for NanoHealth, Swansea University Medical School, Wales, SA2 8PP, UK
| | - Miral Dizdaroglu
- Biomolecular Measurement Division, National Institute of Standards & Technology, Gaithersburg, MD 20899, USA
| | - Bryant C Nelson
- Biosystems & Biomaterials Division, National Institute of Standards & Technology, Gaithersburg, MD 20899, USA
| |
Collapse
|
14
|
Bannuscher A, Schmid O, Drasler B, Rohrbasser A, Braakhuis HM, Meldrum K, Zwart EP, Gremmer ER, Birk B, Rissel M, Landsiedel R, Moschini E, Evans SJ, Kumar P, Orak S, Doryab A, Erdem JS, Serchi T, Vandebriel RJ, Cassee FR, Doak SH, Petri-Fink A, Zienolddiny S, Clift MJD, Rothen-Rutishauser B. An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials. NanoImpact 2022; 28:100439. [PMID: 36402283 DOI: 10.1016/j.impact.2022.100439] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 11/13/2022] [Accepted: 11/14/2022] [Indexed: 06/16/2023]
Abstract
Air-liquid interface (ALI) lung cell models cultured on permeable transwell inserts are increasingly used for respiratory hazard assessment requiring controlled aerosolization and deposition of any material on ALI cells. The approach presented herein aimed to assess the transwell insert-delivered dose of aerosolized materials using the VITROCELL® Cloud12 system, a commercially available aerosol-cell exposure system. An inter-laboratory comparison study was conducted with seven European partners having different levels of experience with the VITROCELL® Cloud12. A standard operating procedure (SOP) was developed and applied by all partners for aerosolized delivery of materials, i.e., a water-soluble molecular substance (fluorescence-spiked salt) and two poorly soluble particles, crystalline silica quartz (DQ12) and titanium dioxide nanoparticles (TiO2 NM-105). The material dose delivered to transwell inserts was quantified with spectrofluorometry (fluorescein) and with the quartz crystal microbalance (QCM) integrated in the VITROCELL® Cloud12 system. The shape and agglomeration state of the deposited particles were confirmed with transmission electron microscopy (TEM). Inter-laboratory comparison of the device-specific performance was conducted in two steps, first for molecular substances (fluorescein-spiked salt), and then for particles. Device- and/or handling-specific differences in aerosol deposition of VITROCELL® Cloud12 systems were characterized in terms of the so-called deposition factor (DF), which allows for prediction of the transwell insert-deposited particle dose from the particle concentration in the aerosolized suspension. Albeit DF varied between the different labs from 0.39 to 0.87 (mean (coefficient of variation (CV)): 0.64 (28%)), the QCM of each VITROCELL® Cloud 12 system accurately measured the respective transwell insert-deposited dose. Aerosolized delivery of DQ12 and TiO2 NM-105 particles showed good linearity (R2 > 0.95) between particle concentration of the aerosolized suspension and QCM-determined insert-delivered particle dose. The VITROCELL® Cloud 12 performance for DQ12 particles was identical to that for fluorescein-spiked salt, i.e., the ratio of measured and salt-predicted dose was 1.0 (29%). On the other hand, a ca. 2-fold reduced dose was observed for TiO2 NM-105 (0.54 (41%)), which was likely due to partial retention of TiO2 NM-105 agglomerates in the vibrating mesh nebulizer of the VITROCELL® Cloud12. This inter-laboratory comparison demonstrates that the QCM integrated in the VITROCELL® Cloud 12 is a reliable tool for dosimetry, which accounts for potential variations of the transwell insert-delivered dose due to device-, handling- and/or material-specific effects. With the detailed protocol presented herein, all seven partner laboratories were able to demonstrate dose-controlled aerosolization of material suspensions using the VITROCELL® Cloud12 exposure system at dose levels relevant for observing in vitro hazard responses. This is an important step towards regulatory approved implementation of ALI lung cell cultures for in vitro hazard assessment of aerosolized materials.
Collapse
Affiliation(s)
- Anne Bannuscher
- Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Otmar Schmid
- Comprehensive Pneumology Center (CPC-M), Helmholtz Zentrum München - Member of the German Center for Lung Research (DZL), Max-Lebsche-Platz 31, 81377 Munich, Germany; Institute of Lung Health and Immunity, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Barbara Drasler
- Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Alain Rohrbasser
- Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Hedwig M Braakhuis
- National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720, BA, Bilthoven, the Netherlands
| | - Kirsty Meldrum
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Medical School, Institute of Life Sciences, Centre for NanoHealth, Swansea University, Singleton Campus, Wales SA2 8PP, UK
| | - Edwin P Zwart
- National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720, BA, Bilthoven, the Netherlands
| | - Eric R Gremmer
- National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720, BA, Bilthoven, the Netherlands
| | - Barbara Birk
- BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen am Rhein, Germany
| | - Manuel Rissel
- BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen am Rhein, Germany
| | - Robert Landsiedel
- BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen am Rhein, Germany; Free University of Berlin, Pharmacy, Pharmacology and Toxicology, 14195 Berlin, Germany
| | - Elisa Moschini
- Department of Environmental Research and Innovation, Luxembourg Institute of Science and Technology (LIST), 41 rue du Brill, L4422 Belvaux, Grand-Duchy of Luxembourg, Luxembourg
| | - Stephen J Evans
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Medical School, Institute of Life Sciences, Centre for NanoHealth, Swansea University, Singleton Campus, Wales SA2 8PP, UK
| | - Pramod Kumar
- Comprehensive Pneumology Center (CPC-M), Helmholtz Zentrum München - Member of the German Center for Lung Research (DZL), Max-Lebsche-Platz 31, 81377 Munich, Germany; Institute of Lung Health and Immunity, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Sezer Orak
- Comprehensive Pneumology Center (CPC-M), Helmholtz Zentrum München - Member of the German Center for Lung Research (DZL), Max-Lebsche-Platz 31, 81377 Munich, Germany; Institute of Lung Health and Immunity, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Ali Doryab
- Comprehensive Pneumology Center (CPC-M), Helmholtz Zentrum München - Member of the German Center for Lung Research (DZL), Max-Lebsche-Platz 31, 81377 Munich, Germany; Institute of Lung Health and Immunity, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | | | - Tommaso Serchi
- Department of Environmental Research and Innovation, Luxembourg Institute of Science and Technology (LIST), 41 rue du Brill, L4422 Belvaux, Grand-Duchy of Luxembourg, Luxembourg
| | - Rob J Vandebriel
- National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720, BA, Bilthoven, the Netherlands
| | - Flemming R Cassee
- National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720, BA, Bilthoven, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| | - Shareen H Doak
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Medical School, Institute of Life Sciences, Centre for NanoHealth, Swansea University, Singleton Campus, Wales SA2 8PP, UK
| | - Alke Petri-Fink
- Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | | | - Martin J D Clift
- In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Medical School, Institute of Life Sciences, Centre for NanoHealth, Swansea University, Singleton Campus, Wales SA2 8PP, UK
| | | |
Collapse
|
15
|
Meldrum K, Moura JA, Doak SH, Clift MJD. Dynamic Fluid Flow Exacerbates the (Pro-)Inflammatory Effects of Aerosolised Engineered Nanomaterials In Vitro. Nanomaterials (Basel) 2022; 12:nano12193431. [PMID: 36234557 PMCID: PMC9565225 DOI: 10.3390/nano12193431] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 09/20/2022] [Accepted: 09/26/2022] [Indexed: 06/08/2023]
Abstract
The majority of in vitro studies focusing upon particle-lung cell interactions use static models at an air-liquid interface (ALI). Advancing the physiological characteristics of such systems allows for closer resemblance of the human lung, in turn promoting 3R strategies. PATROLS (EU Horizon 2020 No. 760813) aimed to use a well-characterised in vitro model of the human alveolar epithelial barrier to determine how fluid-flow dynamics would impact the outputs of the model following particle exposure. Using the QuasiVivoTM (Kirkstall Ltd., York, UK) system, fluid-flow conditions were applied to an A549 + dTHP-1 cell co-culture model cultured at the ALI. DQ12 and TiO2 (JRCNM01005a) were used as model particles to assess the in vitro systems' sensitivity. Using a quasi- and aerosol (VitroCell Cloud12, VitroCell Systems, Waldkirch, Germany) exposure approach, cell cultures were exposed over 24 h at IVIVE concentrations of 1 and 10 (DQ12) and 1.4 and 10.4 (TiO2) µg/cm2, respectively. We compared static and fluid flow conditions after both these exposure methods. The co-culture was subsequently assessed for its viability, membrane integrity and (pro-)inflammatory response (IL-8 and IL-6 production). The results suggested that the addition of fluid flow to this alveolar co-culture model can influence the viability, membrane integrity and inflammatory responses dependent on the particle type and exposure.
Collapse
|
16
|
Siivola KK, Burgum MJ, Suárez-Merino B, Clift MJD, Doak SH, Catalán J. A systematic quality evaluation and review of nanomaterial genotoxicity studies: a regulatory perspective. Part Fibre Toxicol 2022; 19:59. [PMID: 36104711 PMCID: PMC9472411 DOI: 10.1186/s12989-022-00499-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2022] [Accepted: 08/26/2022] [Indexed: 12/29/2022] Open
Abstract
The number of publications in the field of nanogenotoxicology and the amount of genotoxicity data on nanomaterials (NMs) in several databases generated by European Union (EU) funded projects have increased during the last decade. In parallel, large research efforts have contributed to both our understanding of key physico-chemical (PC) parameters regarding NM characterization as well as the limitations of toxicological assays originally designed for soluble chemicals. Hence, it is becoming increasingly clear that not all of these data are reliable or relevant from the regulatory perspective. The aim of this systematic review is to investigate the extent of studies on genotoxicity of NMs that can be considered reliable and relevant by current standards and bring focus to what is needed for a study to be useful from the regulatory point of view. Due to the vast number of studies available, we chose to limit our search to two large groups, which have raised substantial interest in recent years: nanofibers (including nanotubes) and metal-containing nanoparticles. Focusing on peer-reviewed publications, we evaluated the completeness of PC characterization of the tested NMs, documentation of the model system, study design, and results according to the quality assessment approach developed in the EU FP-7 GUIDEnano project. Further, building on recently published recommendations for best practices in nanogenotoxicology research, we created a set of criteria that address assay-specific reliability and relevance for risk assessment purposes. Articles were then reviewed, the qualifying publications discussed, and the most common shortcomings in NM genotoxicity studies highlighted. Moreover, several EU projects under the FP7 and H2020 framework set the aim to collectively feed the information they produced into the eNanoMapper database. As a result, and over the years, the eNanoMapper database has been extended with data of various quality depending on the existing knowledge at the time of entry. These activities are highly relevant since negative results are often not published. Here, we have reviewed the NanoInformaTIX instance under the eNanoMapper database, which hosts data from nine EU initiatives. We evaluated the data quality and the feasibility of use of the data from a regulatory perspective for each experimental entry.
Collapse
Affiliation(s)
- Kirsi K. Siivola
- grid.6975.d0000 0004 0410 5926Finnish Institute of Occupational Health, Box 40, Työterveyslaitos, 00032 Helsinki, Finland
| | - Michael J. Burgum
- grid.4827.90000 0001 0658 8800In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP Wales UK
| | | | - Martin J. D. Clift
- grid.4827.90000 0001 0658 8800In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP Wales UK
| | - Shareen H. Doak
- grid.4827.90000 0001 0658 8800In Vitro Toxicology Group, Faculty of Medicine, Health and Life Sciences, Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP Wales UK
| | - Julia Catalán
- grid.6975.d0000 0004 0410 5926Finnish Institute of Occupational Health, Box 40, Työterveyslaitos, 00032 Helsinki, Finland ,grid.11205.370000 0001 2152 8769Department of Anatomy Embryology and Genetics, University of Zaragoza, 50013 Zaragoza, Spain
| |
Collapse
|
17
|
Evans SJ, Lawrence RL, Ilett M, Burgum MJ, Meldrum K, Hondow N, Jenkins GJ, Clift MJD, Doak SH. Industrial-relevant TiO 2 types do not promote cytotoxicity in the A549 or TK6 cell lines regardless of cell specific interaction. Toxicol In Vitro 2022; 83:105415. [PMID: 35752104 DOI: 10.1016/j.tiv.2022.105415] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 03/07/2022] [Accepted: 06/04/2022] [Indexed: 01/09/2023]
Abstract
Due to the expansive application of TiO2 and its variance in physico-chemical characteristics, the toxicological profile of TiO2, in all its various forms, requires evaluation. This study aimed to assess the hazard of five TiO2 particle-types in relation to their cytotoxic profile correlated to their cellular interaction, specifically in human lymphoblast (TK6) and type-II alveolar epithelial (A549) cells. Treatment with the test materials was undertaken at a concentration range of 1-100 μg/cm2 over 24 and 72 h exposure. TiO2 interaction with both cell types was visualised by transmission electron microscopy, supported by energy-dispersive X-ray. None of the TiO2 materials tested promoted cytotoxicity in either cell type over the concentration and time range studied. All materials were observed to interact with the A549 cells and were further noted to be internalised following 24 h exposure. In contrast, only the pigmentary rutile was internalised by TK6 lymphoblasts after 24 h exposure. Where uptake was observed there was no evidence, as determined by 2D microscopy techniques, of particle localisation within the nucleus of either cell type. This study indicates that industrially relevant TiO2 particles demonstrate cell interactions that are cell-type dependent and do not induce cytotoxicity at the applied dose range.
Collapse
Affiliation(s)
- Stephen J Evans
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Rachel L Lawrence
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Martha Ilett
- School of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK
| | - Michael J Burgum
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Kirsty Meldrum
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Nicole Hondow
- School of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK
| | - Gareth J Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| |
Collapse
|
18
|
Elespuru RK, Doak SH, Collins AR, Dusinska M, Pfuhler S, Manjanatha M, Cardoso R, Chen CL. Common Considerations for Genotoxicity Assessment of Nanomaterials. Front Toxicol 2022; 4:859122. [PMID: 35686044 PMCID: PMC9171035 DOI: 10.3389/ftox.2022.859122] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Accepted: 05/02/2022] [Indexed: 12/27/2022] Open
Abstract
Genotoxicity testing is performed to determine potential hazard of a chemical or agent for direct or indirect DNA interaction. Testing may be a surrogate for assessment of heritable genetic risk or carcinogenic risk. Testing of nanomaterials (NM) for hazard identification is generally understood to require a departure from normal testing procedures found in international standards and guidelines. A critique of the genotoxicity literature in Elespuru et al., 2018, reinforced evidence of problems with genotoxicity assessment of nanomaterials (NM) noted by many previously. A follow-up to the critique of problems (what is wrong) is a series of methods papers in this journal designed to provide practical information on what is appropriate (right) in the performance of genotoxicity assays altered for NM assessment. In this “Common Considerations” paper, general considerations are addressed, including NM characterization, sample preparation, dosing choice, exposure assessment (uptake) and data analysis that are applicable to any NM genotoxicity assessment. Recommended methods for specific assays are presented in a series of additional papers in this special issue of the journal devoted to toxicology methods for assessment of nanomaterials: the In vitro Micronucleus Assay, TK Mutagenicity assays, and the In vivo Comet Assay. In this context, NM are considered generally as insoluble particles or test articles in the nanometer size range that present difficulties in assessment using techniques described in standards such as OECD guidelines.
Collapse
Affiliation(s)
- Rosalie K. Elespuru
- Division of Biology, Chemistry and Materials Science, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD, United States
- *Correspondence: Rosalie K. Elespuru,
| | - Shareen H. Doak
- Institute of Life Science, Swansea University Medical School, Swansea, United Kingdom
| | - Andrew R. Collins
- Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Blindern, Norway
| | - Maria Dusinska
- Health Effects Laboratory, Department of Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway
| | - Stefan Pfuhler
- Global Product Stewardship, Human Safety, Procter & Gamble Mason Business Centre, Mason, OH, United States
| | - Mugimane Manjanatha
- Division of Genetic and Molecular Toxicology, Food and Drug Administration, National Center for Toxicological Research, Jefferson, AR, United States
| | | | - Connie L. Chen
- Health and Environmental Sciences Institute, Washington, DC, MD, United States
| |
Collapse
|
19
|
Doak SH, Clift MJD, Costa A, Delmaar C, Gosens I, Halappanavar S, Kelly S, Pejinenburg WJGM, Rothen-Rutishauser B, Schins RPF, Stone V, Tran L, Vijver MG, Vogel U, Wohlleben W, Cassee FR. The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies. Small 2022; 18:e2200231. [PMID: 35324067 DOI: 10.1002/smll.202200231] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Revised: 02/17/2022] [Indexed: 06/14/2023]
Abstract
The European Green Deal outlines ambitions to build a more sustainable, climate neutral, and circular economy by 2050. To achieve this, the European Commission has published the Chemicals Strategy for Sustainability: Towards a Toxic-Free Environment, which provides targets for innovation to better protect human and environmental health, including challenges posed by hazardous chemicals and animal testing. The European project PATROLS (Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment) has addressed multiple aspects of the Chemicals Strategy for Sustainability by establishing a battery of new approach methodologies, including physiologically anchored human and environmental hazard assessment tools to evaluate the safety of engineered nanomaterials. PATROLS has delivered and improved innovative tools to support regulatory decision-making processes. These tools also support the need for reducing regulated vertebrate animal testing; when used at an early stage of the innovation pipeline, the PATROLS tools facilitate the safe and sustainable development of new nano-enabled products before they reach the market.
Collapse
Affiliation(s)
- Shareen H Doak
- Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK
| | - Martin J D Clift
- Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK
| | - Anna Costa
- Institute of Science and Technology for Ceramics, CNR-ISTEC-National Research Council of Italy, Faenza, Italy
| | - Christiaan Delmaar
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
| | - Ilse Gosens
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
| | - Sabina Halappanavar
- Environmental Health Science and Research Bureau, Health Canada, Ottawa, K1A0K9, Canada
| | - Sean Kelly
- Nanotechnology Industries Association, Avenue Tervueren 143, Brussels, 1150, Belgium
| | - Willie J G M Pejinenburg
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
- Leiden University, PO Box 9518, Leiden, 2300 RA, the Netherlands
| | | | - Roel P F Schins
- IUF-Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225, Düsseldorf, Germany
| | - Vicki Stone
- School of Engineering and Physical Sciences, Heriot Watt University, Edinburgh, UK
| | - Lang Tran
- Institute of Occupational Medicine (IOM), Edinburgh, Scotland, EH14 4AP, UK
| | - Martina G Vijver
- Leiden University, PO Box 9518, Leiden, 2300 RA, the Netherlands
| | - Ulla Vogel
- National Research Centre for the Working Environment, Copenhagen, DK-2100, Denmark
| | - Wendel Wohlleben
- Advanced Materials Research, BASF SE, 67056, Ludwigshafen, Germany
| | - Flemming R Cassee
- National Institute for Public Health and the Environment Netherlands, PO box 1, Bilthoven, 3720, the Netherlands
- Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
| |
Collapse
|
20
|
Meldrum K, Evans SJ, Vogel U, Tran L, Doak SH, Clift MJD. The influence of exposure approaches to in vitro lung epithelial barrier models to assess engineered nanomaterial hazard. Nanotoxicology 2022; 16:114-134. [PMID: 35343373 DOI: 10.1080/17435390.2022.2051627] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Exposure to engineered nanomaterials (ENM) poses a potential health risk to humans through long-term, repetitive low-dose exposures. Currently, this is not commonplace within in vitro lung cell cultures. Therefore, the purpose of this study was to consider the optimal exposure approach toward determining the stability, sensitivity and validity of using in vitro lung cell mono- and co-cultures to determine ENM hazard. A range of exposure scenarios were conducted with DQ12 (previously established as a positive particle control) (historic and re-activated), TiO2 (JRC NM-105) and BaSO4 (JRC NM-220) on both monocultures of A549 cells as well as co-cultures of A549 cells and differentiated THP-1 cells. Cell cultures were exposed to either a single, or a repeated exposure over 24, 48- or 72-hours at in vivo extrapolated concentrations of 0-5.2 µg/cm2, 0-6 µg/cm2 and 0-1µg/cm2. The focus of this study was the pro-inflammatory, cytotoxic and genotoxic response elicited by these ENMs. Exposure to DQ12 caused pro-inflammatory responses after 48 hours repeat exposures, as well as increases in micronucleus frequency. Neither TiO2 nor BaSO4 elicited a pro-inflammatory response at this time point. However, there was induction of IL-6 after 24 hours TiO2 exposure. In conclusion, it is important to consider the appropriateness of the positive control implemented, the cell culture model, the time of exposure as well as the type of exposure (bolus or fractionated) before establishing if an in vitro model is appropriate to determine the level of response to the specific ENM of interest.
Collapse
Affiliation(s)
- Kirsty Meldrum
- In Vitro Toxicology Group, Swansea University, Swansea, UK
| | | | - Ulla Vogel
- The National Research Centre for the Working Environment, Copenhagen, Denmark
| | - Lang Tran
- Institute of Occupational Medicine (IOM), Edinburgh, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Swansea University, Swansea, UK
| | | |
Collapse
|
21
|
Llewellyn SV, Parak WJ, Hühn J, Burgum MJ, Evans SJ, Chapman KE, Jenkins GJS, Doak SH, Clift MJD. Deducing the cellular mechanisms associated with the potential genotoxic impact of gold and silver engineered nanoparticles upon different lung epithelial cell lines in vitro. Nanotoxicology 2022; 16:52-72. [PMID: 35085458 DOI: 10.1080/17435390.2022.2030823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Human ENP exposure is inevitable and the novel, size-dependent physicochemical properties that enable ENPs to be beneficial in innovative technologies are concomitantly causing heightened public concerns as to their potential adverse effects upon human health. This study aims to deduce the mechanisms associated with potential ENP mediated (geno)toxicity and impact upon telomere integrity, if any, of varying concentrations of both ∼16 nm (4.34 × 10-3 to 17.36 × 10-3 mg/mL) Gold (Au) and ∼14 nm (0.85 × 10-5 to 3.32 × 10-5 mg/mL) Silver (Ag) ENPs upon two commonly used lung epithelial cell lines, 16HBE14o- and A549. Following cytotoxicity analysis (via Trypan Blue and Lactate Dehydrogenase assay), two sub-lethal concentrations were selected for genotoxicity analysis using the cytokinesis-blocked micronucleus assay. Whilst both ENP types induced significant oxidative stress, Ag ENPs (1.66 × 10-5 mg/mL) did not display a significant genotoxic response in either epithelial cell lines, but Au ENPs (8.68 × 10-3 mg/mL) showed a highly significant 2.63-fold and 2.4-fold increase in micronucleus frequency in A549 and 16HBE14o- cells respectively. It is hypothesized that the DNA damage induced by acute 24-h Au ENP exposure resulted in a cell cycle stall indicated by the increased mononuclear cell fraction (>6.0-fold) and cytostasis level. Albeit insignificant, a small reduction in telomere length was observed following acute exposure to both ENPs which could indicate the potential for ENP mediated telomere attrition. Finally, from the data shown, both in vitro lung cell cultures (16HBE14o- and A549) are equally as suitable and reliable for the in vitro ENP hazard identification approach adopted in this study.
Collapse
Affiliation(s)
- Samantha V Llewellyn
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| | - Wolfgang J Parak
- Faculty of Physics, Centre of Hybrid Nanostructures, Universität Hamburg, Hamburg, Germany
| | - Jonas Hühn
- Faculty of Physics, Philipps Universität Marburg, Marburg, Germany
| | - Michael J Burgum
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| | - Stephen J Evans
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| | - Katherine E Chapman
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| | - Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Sciences 1, Swansea University Medical School, Swansea, UK
| |
Collapse
|
22
|
Groff K, Evans SJ, Doak SH, Pfuhler S, Corvi R, Saunders S, Stoddart G. In vitro and integrated in vivo strategies to reduce animal use in genotoxicity testing. Mutagenesis 2021; 36:389-400. [PMID: 34555171 DOI: 10.1093/mutage/geab035] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2021] [Accepted: 09/17/2021] [Indexed: 11/13/2022] Open
Abstract
Scientific, financial, and ethical drivers have led to unprecedented interest in implementing human-relevant, mechanistic in vitro and in silico testing approaches. Further, as non-animal approaches are being developed and validated, researchers are interested in strategies that can immediately reduce the use of animals in toxicology testing. Here, we aim to outline a testing strategy for assessing genotoxicity beginning with standard in vitro methods, such as the bacterial reverse mutation test and the in vitro micronucleus test, followed by a second tier of in vitro assays including those using advanced 3D tissue models. Where regulatory agencies require in vivo testing, one demonstrated strategy is to combine genotoxicity studies traditionally conducted separately into a single test or to integrate genotoxicity studies into other toxicity studies. Standard setting organisations and regulatory agencies have encouraged such strategies, and examples of their use can be found in the scientific literature. Employing approaches outlined here will reduce animal use as well as study time and costs.
Collapse
Affiliation(s)
- Katherine Groff
- PETA Science Consortium International e.V., Stuttgart, Germany
| | | | | | | | - Raffaella Corvi
- European Commission, Joint Research Centre (JRC), Ispra, Italy
| | | | - Gilly Stoddart
- PETA Science Consortium International e.V., Stuttgart, Germany
| |
Collapse
|
23
|
Conway GE, Shah UK, Llewellyn S, Cervena T, Evans SJ, Al Ali AS, Jenkins GJ, Clift MJD, Doak SH. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations. Mutagenesis 2021; 35:319-330. [PMID: 32780103 PMCID: PMC7486679 DOI: 10.1093/mutage/geaa018] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Accepted: 06/23/2020] [Indexed: 02/06/2023] Open
Abstract
Following advancements in the field of genotoxicology, it has become widely accepted that 3D models are not only more physiologically relevant but also have the capacity to elucidate more complex biological processes that standard 2D monocultures are unable to. Whilst 3D liver models have been developed to evaluate the short-term genotoxicity of chemicals, the aim of this study was to develop a 3D model that could be used with the regulatory accepted in vitro micronucleus (MN) following low-dose, longer-term (5 days) exposure to engineered nanomaterials (ENMs). A comparison study was carried out between advanced models generated from two commonly used liver cell lines, namely HepaRG and HepG2, in spheroid format. While both spheroid systems displayed good liver functionality and viability over 14 days, the HepaRG spheroids lacked the capacity to actively proliferate and, therefore, were considered unsuitable for use with the MN assay. This study further demonstrated the efficacy of the in vitro 3D HepG2 model to be used for short-term (24 h) exposures to genotoxic chemicals, aflatoxin B1 (AFB1) and methyl-methanesulfonate (MMS). The 3D HepG2 liver spheroids were shown to be more sensitive to DNA damage induced by AFB1 and MMS when compared to the HepG2 2D monoculture. This 3D model was further developed to allow for longer-term (5 day) ENM exposure. Four days after seeding, HepG2 spheroids were exposed to Zinc Oxide ENM (0–2 µg/ml) for 5 days and assessed using both the cytokinesis-block MN (CBMN) version of the MN assay and the mononuclear MN assay. Following a 5-day exposure, differences in MN frequency were observed between the CBMN and mononuclear MN assay, demonstrating that DNA damage induced within the first few cell cycles is distributed across the mononucleated cell population. Together, this study demonstrates the necessity to adapt the MN assay accordingly, to allow for the accurate assessment of genotoxicity following longer-term, low-dose ENM exposure.
Collapse
Affiliation(s)
- Gillian E Conway
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Ume-Kulsoom Shah
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Samantha Llewellyn
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Tereza Cervena
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK.,Department of Nanotoxicology and Molecular Epidemiology, Institute of Experimental Medicine of the CAS, Prague, Czech Republic
| | - Stephen J Evans
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Abdullah S Al Ali
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Gareth J Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
| |
Collapse
|
24
|
Conway GE, Shah UK, Llewellyn S, Cervena T, Evans SJ, Al Ali AS, Jenkins GJ, Clift MJD, Doak SH. Corrigendum to: Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations. Mutagenesis 2021; 36:265-268. [PMID: 34137428 PMCID: PMC8262377 DOI: 10.1093/mutage/geab013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
25
|
Llewellyn SV, Conway GE, Zanoni I, Jørgensen AK, Shah UK, Seleci DA, Keller JG, Kim JW, Wohlleben W, Jensen KA, Costa A, Jenkins GJS, Clift MJD, Doak SH. Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver. J Nanobiotechnology 2021; 19:193. [PMID: 34183029 PMCID: PMC8240362 DOI: 10.1186/s12951-021-00938-w] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Accepted: 06/13/2021] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND With the continued integration of engineered nanomaterials (ENMs) into everyday applications, it is important to understand their potential for inducing adverse human health effects. However, standard in vitro hazard characterisation approaches suffer limitations for evaluating ENM and so it is imperative to determine these potential hazards under more physiologically relevant and realistic exposure scenarios in target organ systems, to minimise the necessity for in vivo testing. The aim of this study was to determine if acute (24 h) and prolonged (120 h) exposures to five ENMs (TiO2, ZnO, Ag, BaSO4 and CeO2) would have a significantly different toxicological outcome (cytotoxicity, (pro-)inflammatory and genotoxic response) upon 3D human HepG2 liver spheroids. In addition, this study evaluated whether a more realistic, prolonged fractionated and repeated ENM dosing regime induces a significantly different toxicity outcome in liver spheroids as compared to a single, bolus prolonged exposure. RESULTS Whilst it was found that the five ENMs did not impede liver functionality (e.g. albumin and urea production), induce cytotoxicity or an IL-8 (pro-)inflammatory response, all were found to cause significant genotoxicity following acute exposure. Most statistically significant genotoxic responses were not dose-dependent, with the exception of TiO2. Interestingly, the DNA damage effects observed following acute exposures, were not mirrored in the prolonged exposures, where only 0.2-5.0 µg/mL of ZnO ENMs were found to elicit significant (p ≤ 0.05) genotoxicity. When fractionated, repeated exposure regimes were performed with the test ENMs, no significant (p ≥ 0.05) difference was observed when compared to the single, bolus exposure regime. There was < 5.0% cytotoxicity observed across all exposures, and the mean difference in IL-8 cytokine release and genotoxicity between exposure regimes was 3.425 pg/mL and 0.181%, respectively. CONCLUSION In conclusion, whilst there was no difference between a single, bolus or fractionated, repeated ENM prolonged exposure regimes upon the toxicological output of 3D HepG2 liver spheroids, there was a difference between acute and prolonged exposures. This study highlights the importance of evaluating more realistic ENM exposures, thereby providing a future in vitro approach to better support ENM hazard assessment in a routine and easily accessible manner.
Collapse
Affiliation(s)
- Samantha V Llewellyn
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK
| | - Gillian E Conway
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK
| | - Ilaria Zanoni
- Institute of Science and Technology for Ceramics, CNR-ISTEC-National Research Council of Italy, Faenza, Italy
| | - Amalie Kofoed Jørgensen
- National Research Centre for the Working Environment (NRCWE), Lersø Parkallé 105, 2100, Copenhagen, Denmark
| | - Ume-Kulsoom Shah
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK
| | - Didem Ag Seleci
- Advanced Materials Research, Department of Material Physics and Analytics, BASF SE, 67056, Ludwigshafen, Germany.,Advanced Materials Research, Department of Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen, Germany
| | - Johannes G Keller
- Advanced Materials Research, Department of Material Physics and Analytics, BASF SE, 67056, Ludwigshafen, Germany.,Advanced Materials Research, Department of Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen, Germany
| | - Jeong Won Kim
- Korea Research Institute of Standards and Science (KRISS), 267 Gajeong-ro, Daejeon, 34113, Korea
| | - Wendel Wohlleben
- Advanced Materials Research, Department of Material Physics and Analytics, BASF SE, 67056, Ludwigshafen, Germany.,Advanced Materials Research, Department of Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen, Germany
| | - Keld Alstrup Jensen
- National Research Centre for the Working Environment (NRCWE), Lersø Parkallé 105, 2100, Copenhagen, Denmark
| | - Anna Costa
- Institute of Science and Technology for Ceramics, CNR-ISTEC-National Research Council of Italy, Faenza, Italy
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK
| | - Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, UK.
| |
Collapse
|
26
|
Barosova H, Meldrum K, Karakocak BB, Balog S, Doak SH, Petri-Fink A, Clift MJD, Rothen-Rutishauser B. Inter-laboratory variability of A549 epithelial cells grown under submerged and air-liquid interface conditions. Toxicol In Vitro 2021; 75:105178. [PMID: 33905840 DOI: 10.1016/j.tiv.2021.105178] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 03/26/2021] [Accepted: 04/22/2021] [Indexed: 12/21/2022]
Abstract
In vitro cell models offer a unique opportunity for conducting toxicology research, and the human lung adenocarcinoma cell line A549 is commonly used for toxicology testing strategies. It is essential to determine whether the response of these cells grown in different laboratories is consistent. In this study, A549 cells were grown under both submerged and air-liquid interface (ALI) conditions following an identical cell seeding protocol in two independent laboratories. The cells were switched to the ALI after four days of submerged growth, and their behaviour was compared to submerged conditions. The membrane integrity, cell viability, morphology, and (pro-)inflammatory response upon positive control stimuli were assessed at days 3, 5, and 7 under submerged conditions and at days 5, 7, and 10 at the ALI. Due to the high variability of the results between the two laboratories, the experiment was subsequently repeated using identical reagents at one specific time point and condition (day 5 at the ALI). Despite some variability, the results were more comparable, proving that the original protocol necessitated improvements. In conclusion, the use of detailed protocols and consumables from the same providers, special training of personnel for cell handling, and endpoint analysis are critical to obtain reproducible results across independent laboratories.
Collapse
Affiliation(s)
- Hana Barosova
- BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland; Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic
| | - Kirsty Meldrum
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, SA2 8PP, Wales, United Kingdom
| | - Bedia Begum Karakocak
- BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Sandor Balog
- BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Shareen H Doak
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, SA2 8PP, Wales, United Kingdom
| | - Alke Petri-Fink
- BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland
| | - Martin J D Clift
- In Vitro Toxicology Group, Swansea University Medical School, Swansea University, SA2 8PP, Wales, United Kingdom.
| | - Barbara Rothen-Rutishauser
- BioNanomaterials Group, Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, 1700 Fribourg, Switzerland.
| |
Collapse
|
27
|
Llewellyn SV, Niemeijer M, Nymark P, Moné MJ, van de Water B, Conway GE, Jenkins GJS, Doak SH. In Vitro Three-Dimensional Liver Models for Nanomaterial DNA Damage Assessment. Small 2021; 17:e2006055. [PMID: 33448117 DOI: 10.1002/smll.202006055] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Revised: 12/10/2020] [Indexed: 06/12/2023]
Abstract
Whilst the liver possesses the ability to repair and restore sections of damaged tissue following acute injury, prolonged exposure to engineered nanomaterials (ENM) may induce repetitive injury leading to chronic liver disease. Screening ENM cytotoxicity using 3D liver models has recently been performed, but a significant challenge has been the application of such in vitro models for evaluating ENM associated genotoxicity; a vital component of regulatory human health risk assessment. This review considers the benefits, limitations, and adaptations of specific in vitro approaches to assess DNA damage in the liver, whilst identifying critical advancements required to support a multitude of biochemical endpoints, focusing on nano(geno)toxicology (e.g., secondary genotoxicity, DNA damage, and repair following prolonged or repeated exposures).
Collapse
Affiliation(s)
- Samantha V Llewellyn
- In vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Marije Niemeijer
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands
| | - Penny Nymark
- Division of Toxicology, Misvik Biology, Karjakatu 35 B, Turku, FI-20520, Finland
- Institute of Environmental Medicine, Karolinska Institute, Nobels väg 13, Stockholm, 17 177, Sweden
| | - Martijn J Moné
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands
| | - Bob van de Water
- Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, The Netherlands
| | - Gillian E Conway
- In vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Gareth J S Jenkins
- In vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Shareen H Doak
- In vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| |
Collapse
|
28
|
Llewellyn SV, Kämpfer A, Keller JG, Vilsmeier K, Büttner V, Ag Seleci D, Schins RPF, Doak SH, Wohlleben W. Simulating Nanomaterial Transformation in Cascaded Biological Compartments to Enhance the Physiological Relevance of In Vitro Dosing Regimes: Optional or Required? Small 2021; 17:e2004630. [PMID: 33475244 DOI: 10.1002/smll.202004630] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2020] [Revised: 10/09/2020] [Indexed: 06/12/2023]
Abstract
Would an engineered nanomaterial (ENM) still have the same identity once it reaches a secondary target tissue after a journey through several physiological compartments? Probably not. Does it matter? ENM pre-treatments may enhance the physiological relevance of in vitro testing via controlled transformation of the ENM identity. The implications of material transformation upon reactivity, cytotoxicity, inflammatory, and genotoxic potential of Ag and SiO2 ENM on advanced gastro-intestinal tract cell cultures and 3D liver spheroids are demonstrated. Pre-treatments are recommended for certain ENM only.
Collapse
Affiliation(s)
- Samantha V Llewellyn
- In vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Angela Kämpfer
- IUF-Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, Düsseldorf, 40225, Germany
| | - Johannes G Keller
- Advanced Materials Research, Department of Material Physics and Analytics and Department of Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, 67056, Germany
| | - Klaus Vilsmeier
- Advanced Materials Research, Department of Material Physics and Analytics and Department of Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, 67056, Germany
| | - Veronika Büttner
- IUF-Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, Düsseldorf, 40225, Germany
| | - Didem Ag Seleci
- Advanced Materials Research, Department of Material Physics and Analytics and Department of Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, 67056, Germany
| | - Roel P F Schins
- IUF-Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, Düsseldorf, 40225, Germany
| | - Shareen H Doak
- In vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Wendel Wohlleben
- Advanced Materials Research, Department of Material Physics and Analytics and Department of Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, 67056, Germany
| |
Collapse
|
29
|
Burgum MJ, Clift MJD, Evans SJ, Hondow N, Miller M, Lopez SB, Williams A, Tarat A, Jenkins GJ, Doak SH. In Vitro Primary-Indirect Genotoxicity in Bronchial Epithelial Cells Promoted by Industrially Relevant Few-Layer Graphene. Small 2021; 17:e2002551. [PMID: 32734718 DOI: 10.1002/smll.202002551] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 06/05/2020] [Indexed: 06/11/2023]
Abstract
Few-layer graphene (FLG) has garnered much interest owing to applications in hydrogen storage and reinforced nanocomposites. Consequently, these engineered nanomaterials (ENMs) are in high demand, increasing occupational exposure. This investigation seeks to assess the inhalation hazard of industrially relevant FLG engineered with: (i) no surface functional groups (neutral), (ii) amine, and (iii) carboxyl group functionalization. A monoculture of human lung epithelial (16HBE14o- ) cells is exposed to each material for 24-h, followed by cytotoxicity and genotoxicity evaluation using relative population doubling (RPD) and the cytokinesis-blocked micronucleus (CBMN) assay, respectively. Neutral-FLG induces the greatest (two-fold) significant increase (p < 0.05) in micronuclei, whereas carboxyl-FLG does not induce significant (p < 0.05) genotoxicity. These findings correlate to significant (p < 0.05) concentration-dependent increases in interleukin (IL)-8, depletion of intracellular glutathione (rGSH) and a depletion in mitochondrial ATP production. Uptake of FLG is evaluated by transmission electron microscopy, whereby FLG particles are observed within membrane-bound vesicles in the form of large agglomerates (>1 µm diameter). The findings of the present study have demonstrated the capability of neutral-FLG and amine-FLG to induce genotoxicity in 16HBE14o- cells through primary indirect mechanisms, suggesting a possible role for carboxyl groups in scavenging radicals produced via oxidative stress.
Collapse
Affiliation(s)
- Michael J Burgum
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Martin J D Clift
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Stephen J Evans
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Nicole Hondow
- School of Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK
| | - Mark Miller
- Centre for Cardiovascular Science, The University of Edinburgh, Queens Medical Research Institute, Edinburgh, EH16 4TJ, UK
| | | | - Adam Williams
- Department of Physics, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Afshin Tarat
- Perpetuus Carbon Technologies, Unit B1, Olympus Court, Millstream Way, Swansea Vale, Llansamlet, Swansea, SA70AQ, UK
| | - Gareth J Jenkins
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, Wales, SA2 8PP, UK
| |
Collapse
|
30
|
Affiliation(s)
- Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Singleton Park Campus, Swansea, SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Singleton Park Campus, Swansea, SA2 8PP, UK
| |
Collapse
|
31
|
Burgum MJ, Clift MJD, Evans SJ, Hondow N, Tarat A, Jenkins GJ, Doak SH. Few-layer graphene induces both primary and secondary genotoxicity in epithelial barrier models in vitro. J Nanobiotechnology 2021; 19:24. [PMID: 33468168 PMCID: PMC7816456 DOI: 10.1186/s12951-021-00769-9] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 01/06/2021] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Toxicological evaluation of engineered nanomaterials (ENMs) is essential for occupational health and safety, particularly where bulk manufactured ENMs such as few-layer graphene (FLG) are concerned. Additionally, there is a necessity to develop advanced in vitro models when testing ENMs to provide a physiologically relevant alternative to invasive animal experimentation. The aim of this study was to determine the genotoxicity of non-functionalised (neutral), amine- and carboxyl-functionalised FLG upon both human-transformed type-I (TT1) alveolar epithelial cell monocultures, as well as co-cultures of TT1 and differentiated THP-1 monocytes (d.THP-1 (macrophages)). RESULTS In monocultures, TT1 and d.THP-1 macrophages showed a statistically significant (p < 0.05) cytotoxic response with each ENM following 24-h exposures. Monoculture genotoxicity measured by the in vitro cytokinesis blocked micronucleus (CBMN) assay revealed significant (p < 0.05) micronuclei induction at 8 µg/ml for amine- and carboxyl-FLG. Transmission electron microscopy (TEM) revealed ENMs were internalised by TT1 cells within membrane-bound vesicles. In the co-cultures, ENMs induced genotoxicity in the absence of cytotoxic effects. Co-cultures pre-exposed to 1.5 mM N-acetylcysteine (NAC), showed baseline levels of micronuclei induction, indicating that the genotoxicity observed was driven by oxidative stress. CONCLUSIONS Therefore, FLG genotoxicity when examined in monocultures, results in primary-indirect DNA damage; whereas co-cultured cells reveal secondary mechanisms of DNA damage.
Collapse
Affiliation(s)
- Michael J Burgum
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Martin J D Clift
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Stephen J Evans
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Nicole Hondow
- School of Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK
| | - Afshin Tarat
- Perpetuus Carbon Technologies, Unit B1, Olympus Court, Millstream Way, Llansamlet, Swansea Vale, SA70AQ, UK
| | - Gareth J Jenkins
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| |
Collapse
|
32
|
Chapman KE, Wilde EC, Chapman FM, Verma JR, Shah UK, Stannard LM, Seager AL, Tonkin JA, Brown MR, Doherty AT, Johnson GE, Doak SH, Jenkins GJS. Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action. Arch Toxicol 2021; 95:321-336. [PMID: 32910239 PMCID: PMC7811515 DOI: 10.1007/s00204-020-02902-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2020] [Accepted: 09/02/2020] [Indexed: 12/12/2022]
Abstract
Current in vitro genotoxicity tests can produce misleading positive results, indicating an inability to effectively predict a compound's subsequent carcinogenic potential in vivo. Such oversensitivity can incur unnecessary in vivo tests to further investigate positive in vitro results, supporting the need to improve in vitro tests to better inform risk assessment. It is increasingly acknowledged that more informative in vitro tests using multiple endpoints may support the correct identification of carcinogenic potential. The present study, therefore, employed a holistic, multiple-endpoint approach using low doses of selected carcinogens and non-carcinogens (0.001-770 µM) to assess whether these chemicals caused perturbations in molecular and cellular endpoints relating to the Hallmarks of Cancer. Endpoints included micronucleus induction, alterations in gene expression, cell cycle dynamics, cell morphology and bioenergetics in the human lymphoblastoid cell line TK6. Carcinogens ochratoxin A and oestradiol produced greater Integrated Signature of Carcinogenicity scores for the combined endpoints than the "misleading" in vitro positive compounds, quercetin, 2,4-dichlorophenol and quinacrine dihydrochloride and toxic non-carcinogens, caffeine, cycloheximide and phenformin HCl. This study provides compelling evidence that carcinogens can successfully be distinguished from non-carcinogens using a holistic in vitro test system. Avoidance of misleading in vitro outcomes could lead to the reduction and replacement of animals in carcinogenicity testing.
Collapse
Affiliation(s)
- Katherine E Chapman
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK.
| | - Eleanor C Wilde
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Fiona M Chapman
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Jatin R Verma
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Ume-Kulsoom Shah
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Leanne M Stannard
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Anna L Seager
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - James A Tonkin
- College of Engineering, Swansea University, Bay Campus, Swansea, SA1 8EN, UK
| | - M Rowan Brown
- College of Engineering, Swansea University, Bay Campus, Swansea, SA1 8EN, UK
| | - Ann T Doherty
- Discovery Safety, AstraZeneca, DSM, Darwin Building, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
| | - George E Johnson
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Swansea University, Singleton Campus, Swansea, SA2 8PP, UK
| |
Collapse
|
33
|
Shah UK, Verma JR, Chapman KE, Wilde EC, Tonkin JA, Brown MR, Johnson GE, Doak SH, Jenkins GJ. Detection of urethane-induced genotoxicity in vitro using metabolically competent human 2D and 3D spheroid culture models. Mutagenesis 2020; 35:445-452. [PMID: 33219664 DOI: 10.1093/mutage/geaa029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 10/22/2020] [Indexed: 11/14/2022] Open
Abstract
In vitro genotoxicity studies are a quick and high throughput approach to assess the genotoxic potential of chemicals; however, the reliability of these tests and their relevance to in vivo effects depends on the choice of representative cell line and optimisation of assay conditions. For chemicals like urethane that require specific metabolic activation to cause genotoxicity, it is important that in vitro tests are conducted using cell lines exhibiting the activity and induction of CYP450 enzymes, including CYP2E1 enzyme that is important in the metabolism of urethane, at a concentration representing actual or perceived chemical exposure. We compared 2D MCL-5 cells and HepG2 cells with 3D HepG2 hanging drop spheroids to determine the genotoxicity of urethane using the micronucleus assay. Our 2D studies with MCL-5 did not show any statistically significant genotoxicity [99% relative population doubling (RPD)] compared to controls for concentrations and time point tested in vitro. HepG2 cells grown as 2D indicated that exposure to urethane of up to 30 mM for 23 h did not cause any genotoxic effect (102% RPD) but, at higher concentrations, genotoxicity was produced with only 89-85% RPD. Furthermore, an exposure of 20-50 mM for 23 h using 3D hanging drop spheroid assays revealed a higher MN frequency, thus exhibiting in vitro genotoxicity of urethane in metabolically active cell models. In comparison with previous studies, this study indicated that urethane genotoxicity is dose, sensitivity of cell model (2D vs. 3D) and exposure dependent.
Collapse
Affiliation(s)
- Ume-Kulsoom Shah
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, UK
| | - Jatin R Verma
- Associate Scientist, Genetic & Molecular Toxicology, Covance Laboratories Limited, Otley Road, Harrogate, North Yorkshire, UK
| | - Katherine E Chapman
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, UK
| | - Eleanor C Wilde
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, UK
| | - James A Tonkin
- College of Engineering, Bay Campus, Swansea University, Swansea, UK
| | - Martyn R Brown
- College of Engineering, Bay Campus, Swansea University, Swansea, UK
| | - George E Johnson
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, UK
| | - Gareth J Jenkins
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, UK
| |
Collapse
|
34
|
Chapman FM, Sparham C, Hastie C, Sanders DJ, van Egmond R, Chapman KE, Doak SH, Scott AD, Jenkins GJS. Comparison of passive-dosed and solvent spiked exposures of pro-carcinogen, benzo[a]pyrene, to human lymphoblastoid cell line, MCL-5. Toxicol In Vitro 2020; 67:104905. [PMID: 32497684 DOI: 10.1016/j.tiv.2020.104905] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Revised: 02/26/2020] [Accepted: 05/28/2020] [Indexed: 11/17/2022]
Abstract
Genotoxicity testing methods in vitro provide a means to predict the DNA damaging effects of chemicals on human cells. This is hindered in the case of hydrophobic test compounds, however, which will partition to in vitro components such as plastic-ware and medium proteins, in preference to the aqueous phase of the exposure medium. This affects the freely available test chemical concentration, and as this freely dissolved aqueous concentration is that bioavailable to cells, it is important to define and maintain this exposure. Passive dosing promises to have an advantage over traditional 'solvent spiking' exposure methods and involves the establishment and maintenance of known chemical concentrations in the in vitro medium, and therefore aqueous phase. Passive dosing was applied in a novel format to expose the MCL-5 human lymphoblastoid cell line to the pro-carcinogen, benzo[a]pyrene (B[a]P) and was compared to solvent (dimethyl sulphoxide) spiked B[a]P exposures over 48 h. Passive dosing induced greater changes, at lower concentrations, to micronucleus frequency, p21 mRNA expression, cell cycle abnormalities, and cell and nuclear morphology. This was attributed to a maintained, definable, free chemical concentration using passive dosing and the presence or absence of solvent, and highlights the influence of exposure choice on genotoxic outcomes.
Collapse
Affiliation(s)
- Fiona M Chapman
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Singleton Campus, Swansea SA2 8PP, UK.
| | - Chris Sparham
- Safety and Environmental Assurance Centre, Unilever, Colworth House, Sharnbrook, Bedford MK44 1LQ, UK
| | - Colin Hastie
- Safety and Environmental Assurance Centre, Unilever, Colworth House, Sharnbrook, Bedford MK44 1LQ, UK
| | - David J Sanders
- Safety and Environmental Assurance Centre, Unilever, Colworth House, Sharnbrook, Bedford MK44 1LQ, UK
| | - Roger van Egmond
- Safety and Environmental Assurance Centre, Unilever, Colworth House, Sharnbrook, Bedford MK44 1LQ, UK
| | - Katherine E Chapman
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Singleton Campus, Swansea SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Singleton Campus, Swansea SA2 8PP, UK
| | - Andrew D Scott
- Safety and Environmental Assurance Centre, Unilever, Colworth House, Sharnbrook, Bedford MK44 1LQ, UK
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Science 1, Swansea University Medical School, Singleton Campus, Swansea SA2 8PP, UK
| |
Collapse
|
35
|
Clift MJD, Jenkins GJS, Doak SH. An Alternative Perspective towards Reducing the Risk of Engineered Nanomaterials to Human Health. Small 2020; 16:e2002002. [PMID: 32755066 DOI: 10.1002/smll.202002002] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Revised: 07/09/2020] [Indexed: 06/11/2023]
Abstract
To elucidate the impact of human exposure to engineered nanomaterials, advanced in vitro models are a valid non-animal alternative. Despite significant gains over the last decade, implementation of these approaches remains limited. This work discusses the current state-of-the-art and how future developments can lead to advanced in vitro models better supporting nano-hazard assessment.
Collapse
Affiliation(s)
- Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Sciences, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, SA2 8PP, UK
| |
Collapse
|
36
|
Ede JD, Lobaskin V, Vogel U, Lynch I, Halappanavar S, Doak SH, Roberts MG, Shatkin JA. Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials. Nanomaterials (Basel) 2020; 10:E1229. [PMID: 32599945 PMCID: PMC7353114 DOI: 10.3390/nano10061229] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Revised: 06/18/2020] [Accepted: 06/19/2020] [Indexed: 02/07/2023]
Abstract
Much of the current innovation in advanced materials is occurring at the nanoscale, specifically in manufactured nanomaterials (MNs). MNs display unique attributes and behaviors, and may be biologically and physically unique, making them valuable across a wide range of applications. However, as the number, diversity and complexity of MNs coming to market continue to grow, assessing their health and environmental risks with traditional animal testing approaches is too time- and cost-intensive to be practical, and is undesirable for ethical reasons. New approaches are needed that meet current requirements for regulatory risk assessment while reducing reliance on animal testing and enabling safer-by-design product development strategies to be implemented. The adverse outcome pathway (AOP) framework presents a sound model for the advancement of MN decision making. Yet, there are currently gaps in technical and policy aspects of AOPs that hinder the adoption and use for MN risk assessment and regulatory decision making. This review outlines the current status and next steps for the development and use of the AOP framework in decision making regarding the safety of MNs. Opportunities and challenges are identified concerning the advancement and adoption of AOPs as part of an integrated approach to testing and assessing (IATA) MNs, as are specific actions proposed to advance the development, use and acceptance of the AOP framework and associated testing strategies for MN risk assessment and decision making. The intention of this review is to reflect the views of a diversity of stakeholders including experts, researchers, policymakers, regulators, risk assessors and industry representatives on the current status, needs and requirements to facilitate the future use of AOPs in MN risk assessment. It incorporates the views and feedback of experts that participated in two workshops hosted as part of an Organization for Economic Cooperation and Development (OECD) Working Party on Manufactured Nanomaterials (WPMN) project titled, "Advancing AOP Development for Nanomaterial Risk Assessment and Categorization", as well as input from several EU-funded nanosafety research consortia.
Collapse
Affiliation(s)
| | - Vladimir Lobaskin
- School of Physics, University College Dublin, Belfield, Dublin 4, Ireland;
| | - Ulla Vogel
- National Research Centre for the Working Environment, DK-2100 Copenhagen, Denmark;
| | - Iseult Lynch
- School of Geography, Earth and Environmental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK;
| | - Sabina Halappanavar
- Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON K1A 0K9, Canada;
| | - Shareen H. Doak
- Institute of Life Sciences, Swansea University Medical School, Singleton Park, Swansea SA2 8PP, UK;
| | - Megan G. Roberts
- Department of Chemistry, University of Toronto, Toronto, ON M5S 3H6, Canada;
| | | |
Collapse
|
37
|
Abstract
Development and application of nanotechnology-enabled medical products, including drugs, devices, and in vitro diagnostics, are rapidly expanding in the global marketplace. In this review, the focus is on providing the reader with an introduction to the landscape of commercially available nanotechnology-enabled medical products as well as an overview of the international documentary standards and reference materials that support and facilitate efficient regulatory evaluation and reliable manufacturing of this diverse group of medical products. We describe the materials, test methods, and standards development needs for emerging medical products. Scientific and measurement challenges involved in the development and application of innovative nanoenabled medical products motivate discussion throughout this review.
Collapse
Affiliation(s)
- Bryant C Nelson
- National Institute of Standards and Technology (NIST), Biosystems and Biomaterials Division, Gaithersburg, Maryland 20899, USA;
| | - Caterina Minelli
- National Physical Laboratory, Chemical and Biological Science Department, Teddington TW11 0LW, United Kingdom
| | - Shareen H Doak
- Swansea University Medical School, Institute of Life Sciences, Swansea SA2 8PP, Wales, United Kingdom
| | - Matthias Roesslein
- Swiss Federal Laboratories for Materials Science and Technology (EMPA), Materials Meet Life Department, CH-9014 St. Gallen, Switzerland
| |
Collapse
|
38
|
Llewellyn SV, Conway GE, Shah UK, Evans SJ, Jenkins GJS, Clift MJD, Doak SH. Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure. J Vis Exp 2020. [PMID: 32568251 DOI: 10.3791/61141] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Abstract
Due to the rapid development and implementation of a diverse array of engineered nanomaterials (ENM), exposure to ENM is inevitable and the development of robust, predictive in vitro test systems is essential. Hepatic toxicology is key when considering ENM exposure, as the liver serves a vital role in metabolic homeostasis and detoxification as well as being a major site of ENM accumulation post exposure. Based upon this and the accepted understanding that 2D hepatocyte models do not accurately mimic the complexities of intricate multi-cellular interactions and metabolic activity observed in vivo, there is a greater focus on the development of physiologically relevant 3D liver models tailored for ENM hazard assessment purposes in vitro. In line with the principles of the 3Rs to replace, reduce and refine animal experimentation, a 3D HepG2 cell-line based liver model has been developed, which is a user friendly, cost effective system that can support both extended and repeated ENM exposure regimes (≤14 days). These spheroid models (≥500 µm in diameter) retain their proliferative capacity (i.e., dividing cell models) allowing them to be coupled with the 'gold standard' micronucleus assay to effectively assess genotoxicity in vitro. Their ability to report on a range of toxicological endpoints (e.g., liver function, (pro-)inflammatory response, cytotoxicity and genotoxicity) has been characterized using several ENMs across both acute (24 h) and long-term (120 h) exposure regimes. This 3D in vitro hepatic model has the capacity to be utilized for evaluating more realistic ENM exposures, thereby providing a future in vitro approach to better support ENM hazard assessment in a routine and easily accessible manner.
Collapse
Affiliation(s)
| | | | | | - Stephen J Evans
- In vitro Toxicology Group, Swansea University Medical School
| | | | | | - Shareen H Doak
- In vitro Toxicology Group, Swansea University Medical School;
| |
Collapse
|
39
|
Cronin JG, Jones N, Thornton CA, Jenkins GJS, Doak SH, Clift MJD. Nanomaterials and Innate Immunity: A Perspective of the Current Status in Nanosafety. Chem Res Toxicol 2020; 33:1061-1073. [PMID: 32307980 DOI: 10.1021/acs.chemrestox.0c00051] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Human exposure to engineered nanomaterials (ENMs) is inevitable due to the plethora of applications for which they are being manufactured and integrated within. ENMs demonstrate plentiful advantages in terms of industrial approaches as well as from a consumer perspective. However, despite such positives, doubts remain over the human health implications of ENM exposure. In light of the increased research focus upon the potential effects of ENM exposure to human health in recent decades, questions still remain regarding the safety of these highly advanced, precision-tuned physical entities. The risk of short-term, high-dose exposure to humans is considered relatively low, although this has formed the direction of the hazard-assessment community since the turn of the 21st century. However, the possibility of humans being exposed repeatedly over a long period of time to a low-dose of ENMs of varying physicochemical characteristics is of significant concern, and thus, industry, government, academic, and consumer agencies are only now beginning to consider this. Notably, when considering the human health implications of such low-dose, long-term, repeated exposure scenarios, the impact of ENMs upon the human immune system is of primary importance. However, there remains a real need to understand the impact of ENMs upon the human immune system, especially the innate immune system, at all stages of life, given exposure to nanosized particles begins before birth, that is, of the fetus. Therefore, the purpose of this perspective is to summarize what is currently known regarding ENM exposure of different components of the innate immune system and identify knowledge gaps that should be addressed if we are to fully deduce the impact of ENM exposure on innate immune function.
Collapse
Affiliation(s)
- James G Cronin
- Immunometabolism & Cancer Research Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, U.K
| | - Nicholas Jones
- Human Immunology Research Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, U.K
| | - Catherine A Thornton
- Human Immunology Research Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, U.K
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, U.K
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, U.K
| | - Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, U.K
| |
Collapse
|
40
|
Pfuhler S, van Benthem J, Curren R, Doak SH, Dusinska M, Hayashi M, Heflich RH, Kidd D, Kirkland D, Luan Y, Ouedraogo G, Reisinger K, Sofuni T, van Acker F, Yang Y, Corvi R. Use of in vitro 3D tissue models in genotoxicity testing: Strategic fit, validation status and way forward. Report of the working group from the 7 th International Workshop on Genotoxicity Testing (IWGT). Mutat Res 2020; 850-851:503135. [PMID: 32247552 DOI: 10.1016/j.mrgentox.2020.503135] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Accepted: 01/09/2020] [Indexed: 12/25/2022]
Abstract
Use of three-dimensional (3D) tissue equivalents in toxicology has been increasing over the last decade as novel preclinical test systems and as alternatives to animal testing. In the area of genetic toxicology, progress has been made with establishing robust protocols for skin, airway (lung) and liver tissue equivalents. In light of these advancements, a "Use of 3D Tissues in Genotoxicity Testing" working group (WG) met at the 7th IWGT meeting in Tokyo in November 2017 to discuss progress with these models and how they may fit into a genotoxicity testing strategy. The workshop demonstrated that skin models have reached an advanced state of validation following over 10 years of development, while liver and airway model-based genotoxicity assays show promise but are at an early stage of development. Further effort in liver and airway model-based assays is needed to address the lack of coverage of the three main endpoints of genotoxicity (mutagenicity, clastogenicity and aneugenicity), and information on metabolic competence. The IWGT WG believes that the 3D skin comet and micronucleus assays are now sufficiently validated to undergo an independent peer review of the validation study, followed by development of individual OECD Test Guidelines.
Collapse
Affiliation(s)
- Stefan Pfuhler
- Procter and Gamble, Mason Business Centre, Mason, OH, USA.
| | - Jan van Benthem
- National Institute for Public Health and the Environment, Centre for Health Protection, Bilthoven, the Netherlands
| | - Rodger Curren
- Institute for In Vitro Sciences, Inc., Gaithersburg, MD, USA
| | - Shareen H Doak
- Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Maria Dusinska
- Health Effects Laboratory, Department of Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway
| | | | - Robert H Heflich
- U.S. Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA
| | - Darren Kidd
- Covance Laboratories Ltd, Otley Road, Harrogate, HG3 1PY, UK
| | | | - Yang Luan
- School of Public Health, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, PR China
| | | | | | - Toshio Sofuni
- Formerly National Institute of Health Sciences, Tokyo, Japan
| | | | - Ying Yang
- Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, PR China
| | - Raffaella Corvi
- European Commission, Joint Research Centre (JRC), Ispra, Italy
| |
Collapse
|
41
|
Elespuru R, Pfuhler S, Aardema MJ, Chen T, Doak SH, Doherty A, Farabaugh CS, Kenny J, Manjanatha M, Mahadevan B, Moore MM, Ouédraogo G, Stankowski LF, Tanir JY. Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods. Toxicol Sci 2019; 164:391-416. [PMID: 29701824 DOI: 10.1093/toxsci/kfy100] [Citation(s) in RCA: 56] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Nanomaterials (NMs) present unique challenges in safety evaluation. An international working group, the Genetic Toxicology Technical Committee of the International Life Sciences Institute's Health and Environmental Sciences Institute, has addressed issues related to the genotoxicity assessment of NMs. A critical review of published data has been followed by recommendations on methods alterations and best practices for the standard genotoxicity assays: bacterial reverse mutation (Ames); in vitro mammalian assays for mutations, chromosomal aberrations, micronucleus induction, or DNA strand breaks (comet); and in vivo assays for genetic damage (micronucleus, comet and transgenic mutation assays). The analysis found a great diversity of tests and systems used for in vitro assays; many did not meet criteria for a valid test, and/or did not use validated cells and methods in the Organization for Economic Co-operation and Development Test Guidelines, and so these results could not be interpreted. In vivo assays were less common but better performed. It was not possible to develop conclusions on test system agreement, NM activity, or mechanism of action. However, the limited responses observed for most NMs were consistent with indirect genotoxic effects, rather than direct interaction of NMs with DNA. We propose a revised genotoxicity test battery for NMs that includes in vitro mammalian cell mutagenicity and clastogenicity assessments; in vivo assessments would be added only if warranted by information on specific organ exposure or sequestration of NMs. The bacterial assays are generally uninformative for NMs due to limited particle uptake and possible lack of mechanistic relevance, and are thus omitted in our recommended test battery for NM assessment. Recommendations include NM characterization in the test medium, verification of uptake into target cells, and limited assay-specific methods alterations to avoid interference with uptake or endpoint analysis. These recommendations are summarized in a Roadmap guideline for testing.
Collapse
Affiliation(s)
- Rosalie Elespuru
- Division of Biology, Chemistry and Materials Science, US Food and Drug Administration, CDRH/OSEL, Silver Spring, Maryland 20993
| | - Stefan Pfuhler
- The Procter & Gamble Company, Mason Business Centre, Mason, Ohio 45040
| | | | - Tao Chen
- Division of Genetic and Molecular Toxicology, US Food and Drug Administration, NCTR, Jefferson, Arkansas 72079
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, UK
| | - Ann Doherty
- Discovery Safety, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca Genetic Toxicology, AstraZeneca, Cambridge CB4 0WG, UK
| | | | - Julia Kenny
- Genetic Toxicology & Photosafety, David Jack Centre for Research & Development, GlaxoSmithKline, Ware, Hertfordshire SG12 0DP, UK
| | - Mugimane Manjanatha
- Division of Genetic and Molecular Toxicology, US Food and Drug Administration, NCTR, Jefferson, Arkansas 72079
| | - Brinda Mahadevan
- Global Pre-clinical Development Innovation & Development, Established Pharmaceuticals, Abbott, Mumbai 400072, India
| | | | | | | | - Jennifer Y Tanir
- ILSI Health and Environmental Sciences Institute (HESI), Washington, District of Columbia 20005
| |
Collapse
|
42
|
Evans SJ, Clift MJD, Singh N, Wills JW, Hondow N, Wilkinson TS, Burgum MJ, Brown AP, Jenkins GJ, Doak SH. In vitro detection of in vitro secondary mechanisms of genotoxicity induced by engineered nanomaterials. Part Fibre Toxicol 2019; 16:8. [PMID: 30760282 PMCID: PMC6374901 DOI: 10.1186/s12989-019-0291-7] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2018] [Accepted: 01/29/2019] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND It is well established that toxicological evaluation of engineered nanomaterials (NMs) is vital to ensure the health and safety of those exposed to them. Further, there is a distinct need for the development of advanced physiologically relevant in vitro techniques for NM hazard prediction due to the limited predictive power of current in vitro models and the unsustainability of conducting nano-safety evaluations in vivo. Thus, the purpose of this study was to develop alternative in vitro approaches to assess the potential of NMs to induce genotoxicity by secondary mechanisms. RESULTS This was first undertaken by a conditioned media-based technique, whereby cell culture media was transferred from differentiated THP-1 (dTHP-1) macrophages treated with γ-Fe2O3 or Fe3O4 superparamagnetic iron oxide nanoparticles (SPIONs) to the bronchial cell line 16HBE14o-. Secondly construction and SPION treatment of a co-culture model comprising of 16HBE14o- cells and dTHP-1 macrophages. For both of these approaches no cytotoxicity was detected and chromosomal damage was evaluated by the in vitro micronucleus assay. Genotoxicity assessment was also performed using 16HBE14o- monocultures, which demonstrated only γ-Fe2O3 nanoparticles to be capable of inducing chromosomal damage. In contrast, immune cell conditioned media and dual cell co-culture SPION treatments showed both SPION types to be genotoxic to 16HBE14o- cells due to secondary genotoxicity promoted by SPION-immune cell interaction. CONCLUSIONS The findings of the present study demonstrate that the approach of using single in vitro cell test systems precludes the ability to consider secondary genotoxic mechanisms. Consequently, the use of multi-cell type models is preferable as they better mimic the in vivo environment and thus offer the potential to enhance understanding and detection of a wider breadth of potential damage induced by NMs.
Collapse
Affiliation(s)
- Stephen J Evans
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Martin J D Clift
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Neenu Singh
- Faculty of Health Sciences and Life Sciences, School of Allied Health Sciences, De Montfort University, The Gateway, Leicester, LE1 9BH, UK
| | - John W Wills
- Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK
| | - Nicole Hondow
- School of Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK
| | - Thomas S Wilkinson
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Michael J Burgum
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Andy P Brown
- School of Chemical and Process Engineering, University of Leeds, Leeds, LS2 9JT, UK
| | - Gareth J Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| |
Collapse
|
43
|
Verma JR, Harte DSG, Shah UK, Summers H, Thornton CA, Doak SH, Jenkins GJS, Rees P, Wills JW, Johnson GE. Investigating FlowSight® imaging flow cytometry as a platform to assess chemically induced micronuclei using human lymphoblastoid cells in vitro. Mutagenesis 2019; 33:283-289. [PMID: 30204902 DOI: 10.1093/mutage/gey021] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2018] [Accepted: 08/31/2018] [Indexed: 11/14/2022] Open
Abstract
Use of imaging flow cytometry to assess induced DNA damage via the cytokinesis block micronucleus (CBMN) assay has thus far been limited to radiation dosimetry in human lymphocytes using high end, 'ImageStream X' series imaging cytometers. Its potential to enumerate chemically induced DNA damage using in vitro cell lines remains unexplored. In the present manuscript, we investigate the more affordable FlowSight® imaging cytometry platform to assess in vitro micronucleus (MN) induction in the human lymphoblastoid TK6 and metabolically competent MCL-5 cells treated with Methyl Methane Sulfonate (MMS) (0-5 µg/ml), Carbendazim (0-1.6 µg/ml), and Benzo[a]Pyrene (B[a]P) (0-6.3 µg/ml) for a period of 1.5-2 cell-cycles. Cells were fixed, and nuclei and MN were stained using the fluorescent nuclear dye DRAQ5™. Image acquisition was carried out using a 20X objective on a FlowSight® imaging cytometer (Amnis, part of Merck Millipore) equipped with a 488 nm laser. Populations of ∼20000 brightfield cell images, alongside DRAQ5™ stained nuclei/MN were rapidly collected (≤10 min). Single, in-focus cells suitable for scoring were then isolated using the IDEAS® software. An overlay of the brightfield cell outlines and the DRAQ5 nuclear fluorescence was used to facilitate scoring of mono-, bi-, tri-, and tetra-nucleated cells with or without MN events and in context of the cytoplasmic boundary of the parent cell.To establish the potential of the FlowSight® platform, and to establish 'ground truth' cell classification for the supervised machine learning based scoring algorithm that represents the next stage of our project, the captured images were scored manually. Alongside, MN frequencies were also derived using the 'gold standard' light microscopy and manual scoring. A minimum of 3000 bi-nucleated cells were assessed using both approaches. Using the benchmark dose approach, the comparability of genotoxic potency estimations for the different compounds and cell lines was assessed across the two scoring platforms as highly similar. This study therefore provides essential proof-of-concept that FlowSight® imaging cytometry is capable of reproducing the results of 'gold standard' manual scoring by light microscopy. We conclude that, with the right automated scoring algorithm, imaging flow cytometry could revolutionise the reportability and scoring throughput of the CBMN assay.
Collapse
Affiliation(s)
- Jatin R Verma
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| | - Danielle S G Harte
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| | - Ume-Kulsoom Shah
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| | - Huw Summers
- College of Engineering, Swansea University, Swansea
| | - Catherine A Thornton
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| | - Gareth J S Jenkins
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| | - Paul Rees
- College of Engineering, Swansea University, Swansea
| | - John W Wills
- Department of Veterinary Medicine, School of Biological Sciences, University of Cambridge, Cambridge
| | - George E Johnson
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea
| |
Collapse
|
44
|
Burnell SEA, Spencer-Harty S, Howarth S, Bodger O, Kynaston H, Morgan C, Doak SH. STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells. Sci Rep 2018; 8:6252. [PMID: 29674723 PMCID: PMC5908900 DOI: 10.1038/s41598-018-24655-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Accepted: 04/03/2018] [Indexed: 12/24/2022] Open
Abstract
Six-transmembrane epithelial antigen of the prostate-2 (STEAP2) expression is increased in prostate cancer when compared to normal prostate, suggesting STEAP2 may drive prostate cancer progression. This study aimed to establish the functional role of STEAP2 in prostate tumourigenesis and evaluate if its knockdown resulted in reduced invasive potential of prostate cancer cells. PC3 and LNCaP cells were transfected with STEAP2 siRNA and proliferation, migration, invasion and gene expression analyses were performed. STEAP2 immunohistochemistry was applied to assess the protein expression and localisation according to Gleason score in 164 prostate cancer patients. Invasion significantly decreased in both cell lines following STEAP2 knockdown. PC3 proliferation and migration capacity significantly reduced, while LNCaP cell morphology and growth characteristics were altered. Additionally, STEAP2 downstream targets associated with driving invasion were identified as MMP3, MMP10, MMP13, FGFR4, IL1β, KiSS1 and SERPINE1 in PC3 cells and, MMP7 in LNCaP cells, with CD82 altered in both. In patient tissues, STEAP2 expression was significantly increased in prostate cancer samples and this significantly correlated with Gleason score. These data demonstrate that STEAP2 drives aggressive prostate cancer traits by promoting proliferation, migration and invasion and significantly influencing the transcriptional profile of ten genes underlying the metastatic cascade.
Collapse
Affiliation(s)
- Stephanie E A Burnell
- Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Samantha Spencer-Harty
- Cellular Pathology, Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Sketty Lane, Sketty, Swansea, SA2 8QA, Wales, UK
| | - Suzie Howarth
- Histopathology, Abertawe Bro Morgannwg University Health Board, Morriston Hospital, Heol Maes Eglwys, Morriston, Swansea, SA6 6NL, Wales, UK
| | - Owen Bodger
- Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Howard Kynaston
- Cardiff School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, Wales, UK
| | - Claire Morgan
- Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, UK
| | - Shareen H Doak
- Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, Wales, UK.
| |
Collapse
|
45
|
Wilde EC, Chapman KE, Stannard LM, Seager AL, Brüsehafer K, Shah UK, Tonkin JA, Brown MR, Verma JR, Doherty AT, Johnson GE, Doak SH, Jenkins GJS. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells. Arch Toxicol 2018; 92:935-951. [PMID: 29110037 PMCID: PMC5818597 DOI: 10.1007/s00204-017-2102-y] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Accepted: 10/24/2017] [Indexed: 02/03/2023]
Abstract
Human exposure to carcinogens occurs via a plethora of environmental sources, with 70-90% of cancers caused by extrinsic factors. Aberrant phenotypes induced by such carcinogenic agents may provide universal biomarkers for cancer causation. Both current in vitro genotoxicity tests and the animal-testing paradigm in human cancer risk assessment fail to accurately represent and predict whether a chemical causes human carcinogenesis. The study aimed to establish whether the integrated analysis of multiple cellular endpoints related to the Hallmarks of Cancer could advance in vitro carcinogenicity assessment. Human lymphoblastoid cells (TK6, MCL-5) were treated for either 4 or 23 h with 8 known in vivo carcinogens, with doses up to 50% Relative Population Doubling (maximum 66.6 mM). The adverse effects of carcinogens on wide-ranging aspects of cellular health were quantified using several approaches; these included chromosome damage, cell signalling, cell morphology, cell-cycle dynamics and bioenergetic perturbations. Cell morphology and gene expression alterations proved particularly sensitive for environmental carcinogen identification. Composite scores for the carcinogens' adverse effects revealed that this approach could identify both DNA-reactive and non-DNA reactive carcinogens in vitro. The richer datasets generated proved that the holistic evaluation of integrated phenotypic alterations is valuable for effective in vitro risk assessment, while also supporting animal test replacement. Crucially, the study offers valuable insights into the mechanisms of human carcinogenesis resulting from exposure to chemicals that humans are likely to encounter in their environment. Such an understanding of cancer induction via environmental agents is essential for cancer prevention.
Collapse
Affiliation(s)
- Eleanor C Wilde
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Katherine E Chapman
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK.
| | - Leanne M Stannard
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Anna L Seager
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Katja Brüsehafer
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Ume-Kulsoom Shah
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - James A Tonkin
- College of Engineering, Bay Campus, Swansea University, Swansea, SA1 8EN, UK
| | - M Rowan Brown
- College of Engineering, Bay Campus, Swansea University, Swansea, SA1 8EN, UK
| | - Jatin R Verma
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Ann T Doherty
- AstraZeneca, Discovery Safety, DSM, Darwin Building, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
| | - George E Johnson
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| | - Gareth J S Jenkins
- In Vitro Toxicology Group, Institute of Life Science 1, Singleton Campus, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK
| |
Collapse
|
46
|
Shah UK, Mallia JDO, Singh N, Chapman KE, Doak SH, Jenkins GJ. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2018; 825:51-58. [DOI: 10.1016/j.mrgentox.2017.12.005] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Revised: 12/07/2017] [Accepted: 12/13/2017] [Indexed: 12/30/2022]
|
47
|
Wills JW, Summers HD, Hondow N, Sooresh A, Meissner KE, White PA, Rees P, Brown A, Doak SH. Characterizing Nanoparticles in Biological Matrices: Tipping Points in Agglomeration State and Cellular Delivery In Vitro. ACS Nano 2017; 11:11986-12000. [PMID: 29072897 DOI: 10.1021/acsnano.7b03708] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
Understanding the delivered cellular dose of nanoparticles is imperative in nanomedicine and nanosafety, yet is known to be extremely complex because of multiple interactions between nanoparticles, their environment, and the cells. Here, we use 3-D reconstruction of agglomerates preserved by cryogenic snapshot sampling and imaged by electron microscopy to quantify the "bioavailable dose" that is presented at the cell surface and formed by the process of individual nanoparticle sequestration into agglomerates in the exposure media. Critically, using 20 and 40 nm carboxylated polystyrene-latex and 16 and 85 nm silicon dioxide nanoparticles, we show that abrupt, dose-dependent "tipping points" in agglomeration state can arise, subsequently affecting cellular delivery and increasing toxicity. These changes are triggered by shifts in the ratio of the total nanoparticle surface area to biomolecule abundance, with the switch to a highly agglomerated state effectively changing the test article midassay, challenging the dose-response paradigm for nanosafety experiments. By characterizing nanoparticle numbers per agglomerate, we show these tipping points can lead to the formation of extreme agglomeration states whereby 90% of an administered dose is contained and delivered to the cells by just the top 2% of the largest agglomerates. We thus demonstrate precise definition, description, and comparison of the nanoparticle dose formed in different experimental environments and show that this description is critical to understanding cellular delivery and toxicity. We further empirically "stress-test" the commonly used dynamic light scattering approach, establishing its limitations to present an analysis strategy that significantly improves the usefulness of this popular nanoparticle characterization technique.
Collapse
Affiliation(s)
- John W Wills
- Institute of Life Sciences, Swansea University Medical School , Singleton Park, Swansea, SA2 8PP, U.K
| | - Huw D Summers
- Centre for Nanohealth, Swansea University College of Engineering , Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, U.K
| | - Nicole Hondow
- School of Chemical and Process Engineering, University of Leeds , Leeds, LS2 9JT, U.K
| | - Aishwarya Sooresh
- Department of Materials Science and Engineering, Texas A&M University , College Station, Texas 77843, United States
| | - Kenith E Meissner
- Department of Biomedical Engineering, Texas A&M University , College Station, Texas 77843, United States
- Department of Physics, Swansea University College of Science , Singleton Park, Swansea, SA2 8PP, U.K
| | - Paul A White
- Department of Biology, University of Ottawa , 30 Marie-Curie Private, Ottawa K1N 9B4, Ontario, Canada
| | - Paul Rees
- Centre for Nanohealth, Swansea University College of Engineering , Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, U.K
- Broad Institute of MIT and Harvard , 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Andy Brown
- School of Chemical and Process Engineering, University of Leeds , Leeds, LS2 9JT, U.K
| | - Shareen H Doak
- Institute of Life Sciences, Swansea University Medical School , Singleton Park, Swansea, SA2 8PP, U.K
| |
Collapse
|
48
|
Theodoulides MK, Clift MJ, Adams R, Webb R, Doak SH. In vitro evaluation of cell signalling processes associated with the potential genotoxicity of metal oxide nanoparticles. Toxicol Lett 2017. [DOI: 10.1016/j.toxlet.2017.07.519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
Stannard L, Doak SH, Doherty A, Jenkins GJ. Is Nickel Chloride really a Non-Genotoxic Carcinogen? Basic Clin Pharmacol Toxicol 2017; 121 Suppl 3:10-15. [PMID: 27748567 DOI: 10.1111/bcpt.12689] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2016] [Accepted: 10/13/2016] [Indexed: 12/16/2022]
Abstract
Human beings are exposed to carcinogens through air, water, food and tobacco smoke. Nickel chloride (NiCl2 ) is a toxic and carcinogenic environmental and occupational pollutant, which was previously classified as a non-genotoxic carcinogen and thought to not directly alter the DNA. Non-genotoxic carcinogens such as NiCl2 are difficult to detect in vitro; hence, a heavy reliance on animal studies exists. NiCl2 has previously been classified as a non-genotoxic carcinogen (NGTC); however, after studying the effect of NiCl2 on many mechanistic end-points, it has become clear that NiCl2 behaves more like a genotoxic carcinogen. The induction of reactive oxygen species (ROS) after treatment with NiCl2 along with positive micronuclei results from a preliminary 5-day chronic dose micronucleus study further supports that NiCl2 has been misclassified as a NGTC. It is possible that NiCl2 causes indirect DNA damage by the production of ROS and requires a longer, chronic exposure, which is more similar to that of human exposure. The focus of this MiniReview is on research into the molecular mechanisms of nickel-induced carcinogenicity and potential genotoxicity, with a focus on one of the salts of greatest commercial importance, nickel chloride.
Collapse
Affiliation(s)
- Leanne Stannard
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, Wales, UK
| | - Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, Wales, UK
| | - Ann Doherty
- Genetic Toxicology, Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, UK
| | - Gareth J Jenkins
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, Wales, UK
| |
Collapse
|
50
|
Abstract
This Mutagenesis special issue is on the topic of nanogenotoxicology. It unites a collection of reports that provide insight into: (i) the properties of engineered nanomaterials (ENMs) that contribute to genotoxicity, (ii) the genotoxic mechanisms associated with DNA damage observed in both in vitro and in vivo tests and (iii) the future test systems that will provide more accurate prediction of ENM genotoxicity to support regulatory hazard assessment frameworks. The contributions within therefore provide collective oversight of our current understanding, coupled to future perspectives aimed at overcoming technical hurdles and describing novel analytical methods to further advance the field.
Collapse
Affiliation(s)
- Shareen H Doak
- In Vitro Toxicology Group, Institute of Life Science and Centre for NanoHealth, Swansea Univeristy Medical School, Swansea University, Singleton Park, Swansea SA2 8PP, Wales, UK and
| | - Maria Dusinska
- Health Effects Group, Department of Environmental Chemistry, NILU- Norwegian Institute for Air Research, N-2027 Kjeller, Norway
| |
Collapse
|